Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 474 articles:
HTML format



Single Articles


    November 2022
  1. JUNG C, Rezar R, Wischmann P, Masyuk M, et al
    The role of anemia on admission in acute coronary syndrome - An umbrella review of systematic reviews and meta-analyses.
    Int J Cardiol. 2022;367:1-10.
    PubMed     Abstract available


  2. GONZALEZ-DEL-HOYO M, Rodriguez-Leor O, Cid-Alvarez AB, de Prado AP, et al
    Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort.
    Int J Cardiol. 2022;367:90-98.
    PubMed     Abstract available


  3. HOLZKNECHT M, Lechner I, Reinstadler SJ
    The circadian clock in STEMI: A further contributor to the development of MVO?
    Int J Cardiol. 2022;367:115-116.
    PubMed    


  4. WANG J, Li Y, Zhang S
    N(6)-methyladenosine modification: A vital role of programmed cell death in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2022;367:11-19.
    PubMed     Abstract available


  5. SIMSEK B, Jaffer FA, Kostantinis S, Karacsonyi J, et al
    Preprocedural coronary computed tomography angiography in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Int J Cardiol. 2022;367:20-25.
    PubMed     Abstract available


  6. ZUERCHER MD, Harvey DJ, Au LE, Shadyab AH, et al
    Genetic admixture and cardiovascular disease risk in postmenopausal Hispanic women.
    Int J Cardiol. 2022;367:99-104.
    PubMed     Abstract available


  7. TORGUSON R, Mintz GS, Case BC, Di Mario C, et al
    Correlation between lipidic content and arterial-wall plaque burden: A Lipid Rich Plaque study sub-analysis.
    Int J Cardiol. 2022;366:32-34.
    PubMed     Abstract available


    October 2022
  8. RUSSO M, Jang IK
    Cholesterol crystals in atherosclerotic plaques: A future target to reduce the risk of plaque rupture?
    Int J Cardiol. 2022;365:30-31.
    PubMed    


  9. MORRONE D, Gentile F, Aimo A, Cameli M, et al
    Perspectives in noninvasive imaging for chronic coronary syndromes.
    Int J Cardiol. 2022;365:19-29.
    PubMed     Abstract available


  10. HONTON B, Lipiecki J, Monsegu J, Leroy F, et al
    Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock Initiative.
    Int J Cardiol. 2022;365:106-111.
    PubMed     Abstract available


  11. FITZGERALD BT, Smith E, Scalia GM
    What are the prognostic implications and factors relating to exercise induced electrocardiographic ST segment changes in the setting of a non-ischemic stress echocardiogram?
    Int J Cardiol. 2022;364:157-161.
    PubMed     Abstract available


  12. QIN Z, Cao M, Xi X, Zhang Y, et al
    Cholesterol crystals in non-culprit plaques of STEMI patients: A 3-vessel OCT study.
    Int J Cardiol. 2022;364:162-168.
    PubMed     Abstract available


  13. COSENTINO N, Lucci C, Marenzi G
    Inflammation and left ventricular thrombosis after STEMI: Risk marker or risk factor?
    Int J Cardiol. 2022;364:16-17.
    PubMed    


  14. YASUE H
    Coronary artery spasm: not rare but not fully understood yet.
    Int J Cardiol. 2022;364:18-19.
    PubMed    


  15. WANG J, Li C, Ding D, Zhang M, et al
    Functional comparison of different jailed balloon techniques in treating non-left main coronary bifurcation lesions.
    Int J Cardiol. 2022;364:20-26.
    PubMed     Abstract available


    September 2022
  16. SOKHAL BS, Matetic A, Paul TK, Velagapudi P, et al
    Management and outcomes of patients admitted with type 2 myocardial infarction with and without standard modifiable risk factors.
    Int J Cardiol. 2022 Sep 18. pii: S0167-5273(22)01387.
    PubMed     Abstract available


  17. DENNIS M, Howpage S, McGill M, Dutta S, et al
    Myocardial fibrosis in Type 2 Diabetes is associated with functional and metabolomic parameters.
    Int J Cardiol. 2022;363:179-184.
    PubMed     Abstract available


  18. DI FUSCO SA, Cianfrocca C, Bisceglia I, Spinelli A, et al
    Potential pathophysiologic mechanisms underlying the inherent risk of cancer in patients with atherosclerotic cardiovascular disease.
    Int J Cardiol. 2022;363:190-195.
    PubMed     Abstract available


  19. ATTAR R, Valentin JB, Andell P, Nielsen RE, et al
    Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder.
    Int J Cardiol. 2022;363:1-5.
    PubMed     Abstract available


  20. YAMAMOTO T, Ishii T, Ishida A
    Impact of post physiological assessment after treatment for de novo coronary lesions using drug-coated balloons.
    Int J Cardiol. 2022;363:11-19.
    PubMed     Abstract available


  21. LIN HC, Chou SH, Fan PC, Zhu Z, et al
    The association between Day-1 urine cadmium excretion and 30-day mortality in patients with acute myocardial infarction: A multi-institutional cohort study.
    Int J Cardiol. 2022 Sep 11. pii: S0167-5273(22)01321.
    PubMed     Abstract available


  22. MICHELSEN HO, Henriksson P, Wallert J, Back M, et al
    Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The perfect-CR study.
    Int J Cardiol. 2022 Sep 8. pii: S0167-5273(22)01322.
    PubMed     Abstract available


  23. SHARMA A, Gupta I, Venkatesh U, Singh AK, et al
    E-cigarettes and myocardial infarction: A systematic review and Meta-analysis.
    Int J Cardiol. 2022 Sep 7. pii: S0167-5273(22)01315.
    PubMed     Abstract available


  24. WIENEMANN H, Ameskamp C, Mejia-Renteria H, Mauri V, et al
    Diagnostic performance of quantitative flow ratio versus fractional flow reserve and resting full-cycle ratio in intermediate coronary lesions.
    Int J Cardiol. 2022;362:59-67.
    PubMed     Abstract available


  25. MATSUBAYASHI K, Soeda T
    Significance of superficial macrophage cluster in coronary atherosclerotic plaque.
    Int J Cardiol. 2022;362:24-25.
    PubMed    


  26. STATHOGIANNIS K, Fearon WF
    Untangling diffuse CAD: Light at the end of the tunnel?
    Int J Cardiol. 2022;362:20-21.
    PubMed    


  27. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Prevalence and outcomes of balloon undilatable chronic total occlusions: Insights from the PROGRESS-CTO.
    Int J Cardiol. 2022;362:42-46.
    PubMed     Abstract available


    August 2022
  28. DEMIRKIRAN A, van der Geest RJ, Hopman LHGA, Robbers LFHJ, et al
    Association of left ventricular flow energetics with remodeling after myocardial infarction: New hemodynamic insights for left ventricular remodeling.
    Int J Cardiol. 2022 Aug 22. pii: S0167-5273(22)01250.
    PubMed     Abstract available


  29. GHAJAR A, Ordonez CP, Philips B, Pinzon PQ, et al
    Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes.
    Int J Cardiol. 2022 Aug 21. pii: S0167-5273(22)01253.
    PubMed     Abstract available


  30. STAHLI BE, Witassek FF, Roffi M, Eberli FR, et al
    Trends in treatment and outcomes of patients with diabetes and acute myocardial infarction: Insights from the nationwide AMIS plus registry.
    Int J Cardiol. 2022 Aug 19. pii: S0167-5273(22)01200.
    PubMed    


  31. DE FILIPPO O, Russo C, Manai R, Borzillo I, et al
    Impact of secondary prevention medical therapies on outcomes of patients suffering from Myocardial Infarction with NonObstructive Coronary Artery disease (MINOCA): A meta-analysis.
    Int J Cardiol. 2022 Aug 17. pii: S0167-5273(22)01201.
    PubMed     Abstract available


  32. MALHOTRA P, Han D
    Imaging tests for coronary artery disease risk assessment: Anatomy, physiology, or both?
    Int J Cardiol. 2022;361:124-125.
    PubMed    


  33. GAUTHIER V, Montaye M, Ferrieres J, Kai SHY, et al
    Sex differences in time trends in acute coronary syndrome management and in 12-month lethality: Data from the French MONICA registries.
    Int J Cardiol. 2022;361:103-108.
    PubMed     Abstract available


  34. GALLINORO E, Almendarez M, Alvarez-Velasco R, Barbato E, et al
    Bioresorbable stents: Is the game over?
    Int J Cardiol. 2022;361:20-28.
    PubMed     Abstract available


  35. MYHRE PL, Rosjo H, Sarvari SI, Ukkonen H, et al
    Cardiac troponin T and NT-proBNP for detecting myocardial ischemia in suspected chronic coronary syndrome.
    Int J Cardiol. 2022;361:14-17.
    PubMed     Abstract available


  36. TANG LH, Harrison A, Skou ST, Taylor RS, et al
    Are patient characteristics and modes of delivery associated with completion of cardiac rehabilitation? A national registry analysis.
    Int J Cardiol. 2022;361:7-13.
    PubMed     Abstract available


  37. MARBACH JA, Faugno AJ, Pacifici S, Chweich H, et al
    Strategies to reduce limb ischemia in peripheral venoarterial extracorporeal membrane oxygenation: A systematic review and Meta-analysis.
    Int J Cardiol. 2022;361:77-84.
    PubMed     Abstract available


  38. LI Q, Xie E, Tu Y, Wu Y, et al
    Association between kaolin-induced maximum amplitude and slow-flow/no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Int J Cardiol. 2022 Aug 12. pii: S0167-5273(22)01193.
    PubMed     Abstract available


  39. CHEN Y, Wu J, Tang Y, Li Z, et al
    Multimorbidity and combined interventions for patients with coronary heart disease in Chinese population: Latent class analysis of a multi-center study.
    Int J Cardiol. 2022 Aug 10. pii: S0167-5273(22)01189.
    PubMed     Abstract available


  40. GRAZIANI F, Lillo R, Biagini E, Limongelli G, et al
    Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease.
    Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01116.
    PubMed     Abstract available


  41. HWANG R, Peters R, Harmer E, Boyde M, et al
    Insight into a real-world experience with completion of cardiac rehabilitation.
    Int J Cardiol. 2022;360:5-6.
    PubMed    


  42. GOEL V, Spear E, Cameron W, Thakur U, et al
    Breast arterial calcification and epicardial adipose tissue volume, but not density are independently associated with cardiovascular risk.
    Int J Cardiol. 2022;360:78-82.
    PubMed     Abstract available


  43. NAKAJIMA K, Yoshida S
    Small coronary artery matters: Non-dominant right coronary artery and perfusion imaging.
    Int J Cardiol. 2022;360:101-103.
    PubMed    


  44. SEITZ A, Martinez Pereyra V, Hubert A, Klingel K, et al
    Epicardial and microvascular coronary artery spasm in biopsy-proven viral myocarditis.
    Int J Cardiol. 2022;360:1-4.
    PubMed     Abstract available


  45. CHAUDHARY R, Bashline M, Novelli EM, Bliden KP, et al
    Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Aug 1. pii: S0167-5273(22)01120.
    PubMed     Abstract available


    July 2022
  46. LUNARDI M, Venturi G, Del Sole PA, Ruzzarin A, et al
    Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Jul 21. pii: S0167-5273(22)01100.
    PubMed     Abstract available


  47. SEITZ A, Martinez Pereyra V, Sechtem U, Ong P, et al
    Update on coronary artery spasm 2022 - A narrative review.
    Int J Cardiol. 2022;359:1-6.
    PubMed     Abstract available


  48. DIXON LK, Akberali U, Di Tommaso E, George SJ, et al
    Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022;359:20-27.
    PubMed     Abstract available


  49. NELEMAN T, Scoccia A, Masdjedi K, Tomaniak M, et al
    The prognostic value of angiography-based vessel fractional flow reserve after percutaneous coronary intervention: The FAST Outcome study.
    Int J Cardiol. 2022;359:14-19.
    PubMed     Abstract available


  50. ZHANG L, Fu Z, Huang Y, Luo W, et al
    LOXL1-AS1 alleviates inflammatory response in the epicardial adipose tissue with coronary artery disease by sponging miR-3614.
    Int J Cardiol. 2022;359:113.
    PubMed    


  51. PRESCOTT E, Angeras O, Erlinge D, Grove EL, et al
    Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study.
    Int J Cardiol. 2022 Jul 13. pii: S0167-5273(22)01084.
    PubMed     Abstract available


  52. BONFIG NL, Soukup CR, Shah AA, Davidson S, et al
    Circadian dependence of microvascular obstruction during ST-segment elevation myocardial infarction.
    Int J Cardiol. 2022 Jul 8. pii: S0167-5273(22)01036.
    PubMed     Abstract available


  53. MPLANI V, Apostolopoulos D, Koufou E, Spyridonidis T, et al
    Inferior myocardial wall ischemia on SPECT-MPI in patients with non dominant right coronary artery and non significant coronary artery disease.
    Int J Cardiol. 2022;358:8-10.
    PubMed     Abstract available


  54. XU JJ, Cui J, Lin Q, Chen XY, et al
    Response to "Involvement of the crosstalk between Nrf2 and NF-kappaB pathways regulated by SIRT1 in myocardial ischemia/reperfusion injury".
    Int J Cardiol. 2022;358:11.
    PubMed    


  55. JAVAID A, Ahmed AI, Han Y, Al Rifai M, et al
    Incremental prognostic value of spect over CCTA.
    Int J Cardiol. 2022;358:120-127.
    PubMed     Abstract available


  56. YU K, Yang C, Liu J, Mo D, et al
    GATA2 might be used to predict the susceptibility of people to coronary artery disease.
    Int J Cardiol. 2022;358:94.
    PubMed    


    June 2022
  57. ORBAN M, Kuehl A, Dischl D, Muller C, et al
    Fibrotic plaques in heart transplanted patients and their association with insulin resistance syndrome and Lp(a).
    Int J Cardiol. 2022 Jun 27. pii: S0167-5273(22)01015.
    PubMed     Abstract available


  58. BAKER HE, Tune JD, Mather KJ, Blaettner BS, et al
    Acute SGLT-2i treatment improves cardiac efficiency during myocardial ischemia independent of Na+/H+ exchanger-1.
    Int J Cardiol. 2022 Jun 23. pii: S0167-5273(22)01006.
    PubMed     Abstract available


  59. YAN H, Zhao N, Geng W, Hou Z, et al
    Pericoronary fat attenuation index and coronary plaque quantified from coronary computed tomography angiography identify ischemia-causing lesions.
    Int J Cardiol. 2022;357:8-13.
    PubMed     Abstract available


  60. KIM HO, Jiang B, Poon EKW, Thondapu V, et al
    High endothelial shear stress and stress gradient at plaque erosion persist up to 12 months.
    Int J Cardiol. 2022;357:1-7.
    PubMed     Abstract available


  61. HIGASHIOKA D, Shiono Y, Emori H, Khalifa AKM, et al
    Prevalence of myocardial perfusion scintigraphy derived ischemia in coronary lesions with discordant fractional flow reserve and non-hyperemic pressure ratios.
    Int J Cardiol. 2022;357:20-25.
    PubMed     Abstract available


  62. NGUYEN HL, Bui QT, Tran HV, Hoang MV, et al
    Characteristics, in-hospital management, and complications of acute myocardial infarction in northern and Central Vietnam.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00943.
    PubMed     Abstract available


  63. SUN M, Dube MP, Hennessy T, Schultz CJ, et al
    Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00926.
    PubMed     Abstract available


  64. SOLLI CN, Chamat-Hedemand S, Elming H, Ngo A, et al
    Coronary artery- and aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00928.
    PubMed     Abstract available


  65. CHOI YJ, Park MJ, Ko Y, Soh MS, et al
    Artificial intelligence versus physicians on interpretation of printed ECG images: Diagnostic performance of ST-elevation myocardial infarction on electrocardiography.
    Int J Cardiol. 2022 Jun 9. pii: S0167-5273(22)00869.
    PubMed     Abstract available


  66. MIR T, Uddin M, Changal K, Qureshi W, et al
    Mortality outcomes and 30-day readmissions associated with coronary artery aneurysms; a National Database Study.
    Int J Cardiol. 2022;356:6-11.
    PubMed     Abstract available


  67. ROONGSANGMANOON W, Wongsoasup A, Angkananard T, Rattanajaruskul N, et al
    Comparison of efficacy and safety of intracoronary nicardipine and adenosine for fractional flow reserve assessment of coronary stenosis.
    Int J Cardiol. 2022;356:1-5.
    PubMed     Abstract available


  68. KAVSAK PA, Mondoux SE, Ainsworth C, Worster A, et al
    High-sensitivity cardiac troponin and the importance of cutoffs in patients with prior coronary artery bypass grafting with suspected NSTEMI.
    Int J Cardiol. 2022;356:36-37.
    PubMed    


  69. AKIMARU K, Iwabuchi M, Ishida A, Uehara H, et al
    Comparative evaluation of standard maintenance-dose clopidogrel versus low-dose prasugrel in patients with stable coronary artery disease after percutaneous coronary intervention.
    Int J Cardiol. 2022;356:30-35.
    PubMed     Abstract available


  70. SIMONI AH, Frydenlund J, Kragholm KH, Boggild H, et al
    Socioeconomic inequity in incidence, outcomes and care for acute coronary syndrome: A systematic review.
    Int J Cardiol. 2022;356:19-29.
    PubMed     Abstract available


    May 2022
  71. KE Y, Wang J, Wang W, Guo S, et al
    Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022 May 30. pii: S0167-5273(22)00807.
    PubMed     Abstract available


  72. PIVATO CA, Chandiramani R, Petrovic M, Nicolas J, et al
    Depression and ischemic heart disease.
    Int J Cardiol. 2022 May 25. pii: S0167-5273(22)00767.
    PubMed     Abstract available


  73. TRAVERSE JH
    When should patients with acute myocardial infarction undergo CABG? A question much in need of a randomized clinical trial?
    Int J Cardiol. 2022 May 25. pii: S0167-5273(22)00768.
    PubMed    


  74. BERNARDI M, Spadafora L, Biondi-Zoccai G, Giordano A, et al
    Juvenile myocardial infarction: Sex matters.
    Int J Cardiol. 2022 May 23. pii: S0167-5273(22)00757.
    PubMed    


  75. FLORIAN A
    Predicting LV thrombosis after acute myocardial infarction: From Virchow's triad to state-of-the-art cardiovascular magnetic resonance imaging.
    Int J Cardiol. 2022 May 18. pii: S0167-5273(22)00745.
    PubMed    


  76. LI Q, Li Z, Li T, Liu C, et al
    Involvement of the crosstalk between Nrf2 and NF-kappaB pathways regulated by SIRT1 in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2022;355:44.
    PubMed    


  77. TSUGU T, Tanaka K, Belsack D, Devos H, et al
    Effects of left ventricular mass on computed tomography derived fractional flow reserve in significant obstructive coronary artery disease.
    Int J Cardiol. 2022;355:59-64.
    PubMed     Abstract available


  78. HOLZKNECHT M, Reinstadler SJ
    CRP: a potential target in reperfused STEMI? Reply to the letter: "Targeting CRP in microvascular obstruction after PCI".
    Int J Cardiol. 2022;355:5.
    PubMed    


  79. DIEU X, Chabrun F, Prunier F, Angoulvant D, et al
    Post-infarct cardiac remodeling predictions with machine learning.
    Int J Cardiol. 2022;355:1-4.
    PubMed     Abstract available


  80. SVARTSTEIN AW, Lassen MH, Skaarup KG, Grove GL, et al
    Predictive value of left atrial strain in relation to atrial fibrillation following acute myocardial infarction.
    Int J Cardiol. 2022 May 13. pii: S0167-5273(22)00736.
    PubMed     Abstract available


  81. SHETTY MK, Kunal S, Girish MP, Qamar A, et al
    Machine learning based model for risk prediction after ST-Elevation myocardial infarction: Insights from the North India ST elevation myocardial infarction (NORIN-STEMI) Registry.
    Int J Cardiol. 2022 May 13. pii: S0167-5273(22)00734.
    PubMed     Abstract available


  82. LECHNER I, Reindl M, Tiller C, Holzknecht M, et al
    Association between inflammation and left ventricular thrombus formation following ST-elevation myocardial infarction.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00660.
    PubMed     Abstract available


  83. IANNACCONE M, Franchin L, Hanson ID, Boccuzzi G, et al
    Timing of impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock: An updated meta-analysis.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00662.
    PubMed     Abstract available


  84. MA F, Hao J, Zhao J, Liu DY, et al
    Circulating FAM19A5 level is associated with the presence and severity of coronary artery disease.
    Int J Cardiol. 2022;354:50-55.
    PubMed     Abstract available


  85. GRAGNANO F, Cesaro A, Pelliccia F, Limongelli G, et al
    Early-onset MINOCA: Prognostic implications and considerations for practice.
    Int J Cardiol. 2022;354:14-16.
    PubMed    


  86. HITOMI Y, Masaki N, Ishinoda Y, Ido Y, et al
    Effectiveness of the d-ROMs oxidative stress test to predict long-term cardiovascular mortality.
    Int J Cardiol. 2022;354:43-47.
    PubMed     Abstract available


  87. KOECHLIN L, Boeddinghaus J, Nestelberger T, Lopez-Ayala P, et al
    Lower diagnostic accuracy of hs-cTnI in patients with prior coronary artery bypass grafting.
    Int J Cardiol. 2022;354:1-6.
    PubMed     Abstract available


    April 2022
  88. WANG Z, Li T, Li M, Gu W, et al
    MALAT1 aggravates cardiomyocytes injury in myocardial infarction by sponging miR-135b.
    Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00636.
    PubMed    


  89. LI J, Chen R, Zhou J, Wang Y, et al
    The relationship between Hemoglobin A1c and the maximal plaque stress of culprit ruptured plaques in patients with ST-segment elevated myocardial infarction.
    Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00634.
    PubMed     Abstract available


  90. BENEDETTO U, Sinha S, Mulla A, Glampson B, et al
    Implications of elevated troponin on time-to-surgery in non-ST elevation myocardial infarction (NIHR Health Informatics Collaborative: TROP-CABG study).
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00586.
    PubMed     Abstract available


  91. FERRELL MC, Elizabeth Garrett BA, Alicia Tomlin DO, Cole Wayant DO, et al
    Editorial conflicts of interest related to the Management of Stable Ischemic Heart Disease.
    Int J Cardiol. 2022 Apr 22. pii: S0167-5273(22)00569.
    PubMed     Abstract available


  92. ORBAN M, Dietl M, Dischl D, von Samson-Himmelstjerna P, et al
    Assessment of sex- and age-dependency of risk factors for intimal hyperplasia in heart transplant patients using the high resolution of optical coherence tomography.
    Int J Cardiol. 2022 Apr 18. pii: S0167-5273(22)00556.
    PubMed     Abstract available


  93. CAO M, Luo H, Li D, Wang S, et al
    Research advances on circulating long noncoding RNAs as biomarkers of cardiovascular diseases.
    Int J Cardiol. 2022;353:109-117.
    PubMed     Abstract available


  94. SCICALI R
    Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease.
    Int J Cardiol. 2022;353:118.
    PubMed    


  95. ZHAO Z, Shi Q, Guo Q, Peng L, et al
    Remote ischemic preconditioning can extend the tolerance to extended drug-coated balloon inflation time by reducing myocardial damage during percutaneous coronary intervention.
    Int J Cardiol. 2022;353:3-8.
    PubMed     Abstract available


  96. D'ASCENZO F, Elia E, de Filippo O, Manai R, et al
    Net clinical benefit of different strategies of dual antiplatelet therapy in elderly patients: Data from the praise registry.
    Int J Cardiol. 2022;353:9-14.
    PubMed     Abstract available


  97. NANDHAKUMAR V, Pakshirajan B, Chopra A, Anandan H, et al
    Safety and feasibility of intravascular ultrasound guided zero-contrast percutaneous coronary intervention-A prospective study.
    Int J Cardiol. 2022;353:22-28.
    PubMed     Abstract available


  98. MASSUSSI M, Cipriani A, Meneghin S, De la Cruz N, et al
    Prognostic value of left ventricular blood stasis in patients with acute myocardial infarction: A cardiac magnetic resonance study.
    Int J Cardiol. 2022 Apr 6. pii: S0167-5273(22)00492.
    PubMed     Abstract available


  99. BOTTO GL, Mantovani LG, Cortesi PA, De Ponti R, et al
    The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00483.
    PubMed     Abstract available


  100. MAHABADI AA, Anapliotis V, Dykun I, Hendricks S, et al
    Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00489.
    PubMed     Abstract available


  101. ONG P, Allgauer S
    Factors influencing medical care of STEMI patients during the COVID-19 pandemic worldwide.
    Int J Cardiol. 2022;352:195-196.
    PubMed    


  102. LV R, Wang L, Maehara A, Guo X, et al
    Image-based biomechanical modeling for coronary atherosclerotic plaque progression and vulnerability prediction.
    Int J Cardiol. 2022;352:1-8.
    PubMed     Abstract available


  103. VYNCKIER P, Kotseva K, Gevaert S, De Bacquer D, et al
    Gender differences in cardiovascular risk factor awareness: Results from the ESC EORP EUROASPIRE V Registry.
    Int J Cardiol. 2022;352:152-157.
    PubMed     Abstract available


  104. GALLINORO E, Monizzi G, Sonck J, Candreva A, et al
    Physiological and angiographic outcomes of PCI in calcified lesions after rotational atherectomy or intravascular lithotripsy.
    Int J Cardiol. 2022;352:27-32.
    PubMed     Abstract available


  105. ZHANG D, Wu H, Liu D, Li Y, et al
    Targeting CRP in microvascular obstruction after PCI.
    Int J Cardiol. 2022;352:124.
    PubMed    


  106. ZHANG R, Xu B, Dou K, Guan C, et al
    Post-PCI outcomes predicted by pre-intervention simulation of residual quantitative flow ratio using augmented reality.
    Int J Cardiol. 2022;352:33-39.
    PubMed     Abstract available


  107. SCHAFER A
    Clopidogrel or ticagrelor in elderly patients with acute coronary syndromes - Nihil nocere!
    Int J Cardiol. 2022;352:19-20.
    PubMed    


  108. VAN BEEK KAJ, van Steenbergen GJ, Vervaat FE, Mulders BCJH, et al
    Single center experience in the treatment of hemodynamically significant diffuse coronary artery disease of the left anterior descending.
    Int J Cardiol. 2022;352:40-44.
    PubMed     Abstract available


  109. MASCI PG, Bogaert J
    Implementing the risk stratification in STEMI by cardiovascular magnetic resonance: An academic exercise or real benefit?
    Int J Cardiol. 2022;352:188-189.
    PubMed    


    March 2022
  110. WANG W, Huang Q, Pan D, Zheng W, et al
    The optimal duration of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Int J Cardiol. 2022 Mar 29. pii: S0167-5273(22)00441.
    PubMed     Abstract available


  111. ZHANG Y
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Mar 18. pii: S0167-5273(22)00389.
    PubMed    


  112. GONZALEZ FERRERO T, Alvarez Alvarez B, Cordero A, Martinon Martinez J, et al
    Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: The cardio CHUS-HUSJ registry.
    Int J Cardiol. 2022;351:8-14.
    PubMed     Abstract available


  113. DEMIRCI D, Demirci DE, Chi G
    Association between obesity grade and the age of the first acute coronary syndrome: Prospective observational study.
    Int J Cardiol. 2022;351:93-99.
    PubMed     Abstract available


  114. REINSTADLER SJ, Dlaska C, Reindl M, Marks M, et al
    Predicting cardiac remodeling after myocardial infarction with machine learning: are we there yet?
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00335.
    PubMed    


  115. BRUNO F, Moirano G, Budano C, Lalloni S, et al
    Incidence trends and long-term outcomes of myocardial infarction in young adults: Does gender matter?
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00331.
    PubMed     Abstract available


  116. CIFKOVA R
    Gender differences in secondary prevention of coronary heart disease: Far from closing the gap.
    Int J Cardiol. 2022 Mar 10. pii: S0167-5273(22)00322.
    PubMed    


  117. MONTINARI MR, Minelli P, Russo A, Gianicolo E, et al
    Patterns of coronary heart disease mortality in Italy from 1931 to 2015 and a focus on a region with highly industrialized areas.
    Int J Cardiol. 2022 Mar 9. pii: S0167-5273(22)00326.
    PubMed     Abstract available


  118. ZANCHIN C, Ledwoch S, Bar S, Ueki Y, et al
    Acute coronary syndromes in young patients: Phenotypes, causes and clinical outcomes following percutaneous coronary interventions.
    Int J Cardiol. 2022;350:1-8.
    PubMed     Abstract available


  119. PENG J, Xing CY, Zhao K, Deng J, et al
    Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease: A case-control study.
    Int J Cardiol. 2022;350:9-15.
    PubMed     Abstract available


  120. MATSUI S, Maruhashi T, Kishimoto S, Kajikawa M, et al
    Poor tooth brushing behavior is associated with high risk of cardiovascular events: A prospective observational study.
    Int J Cardiol. 2022;350:111-117.
    PubMed     Abstract available


  121. WU J, Huang Y, Zhang J, Xiang Z, et al
    LncRNA CPhar mediates exercise-induced cardioprotection by promoting eNOS phosphorylation at Ser1177 via DDX17/PI3K/Akt pathway after MI/RI.
    Int J Cardiol. 2022;350:16.
    PubMed    


    February 2022
  122. LU Y, Tian Y, Mou T, Zhou Y, et al
    Transient cardioprotective effects of remote ischemic postconditioning on non-reperfused myocardial infarction: longitudinal evaluation study in pigs.
    Int J Cardiol. 2022 Feb 18. pii: S0167-5273(22)00257.
    PubMed     Abstract available


  123. TILLER C, Reindl M, Reinstadler SJ, Klug G, et al
    The classical 12lead ECG: Much more to offer than just a diagnosis in STEMI?
    Int J Cardiol. 2022;349:29-30.
    PubMed    


  124. FUJISUE K, Yamamoto E, Sueta D, Takae M, et al
    Increased soluble programed cell death-ligand 1 is associated with acute coronary syndrome.
    Int J Cardiol. 2022;349:1-6.
    PubMed     Abstract available


  125. FERRO A
    Antithrombotic therapy after 1 year of dual antiplatelet therapy following acute coronary syndrome: What to do?
    Int J Cardiol. 2022;349:27-28.
    PubMed    


  126. SAITO Y, Saito Y, Kato K, Kobayashi Y, et al
    Gender differences in factors associated with vasospastic angina.
    Int J Cardiol. 2022;349:7-11.
    PubMed     Abstract available


  127. MAGNANI G, Bricoli S, Ardissino M, Maglietta G, et al
    Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA).
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00249.
    PubMed     Abstract available


  128. FAGA V, Anguera I, Oloriz T, Nombela-Franco L, et al
    Improved prediction of electrical storm in patients with prior myocardial infarction and implantable cardioverter defibrillator.
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00251.
    PubMed     Abstract available


  129. MANTOVANI A, Bonapace S, Dugo C, Beatrice G, et al
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Feb 12. pii: S0167-5273(22)00248.
    PubMed     Abstract available


  130. MARENGO G, De Filippo O, D'Ascenzo F, Iannaccone M, et al
    IVUS guided PCI in patients with acute myocardial infarction - The route toward a "plaque oriented" PCI.
    Int J Cardiol. 2022 Feb 11. pii: S0167-5273(22)00246.
    PubMed    


  131. GIRERD N
    The growing importance of heart failure in myocardial infarction.
    Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00194.
    PubMed    


  132. HOLZKNECHT M, Klug G, Metzler B, Reinstadler SJ, et al
    Mechanical complications after STEMI: Another collateral damage of the COVID-19 pandemic.
    Int J Cardiol. 2022;348:23-25.
    PubMed    


  133. ASAKURA K, Minami Y, Kinoshita D, Katamine M, et al
    Impact of triglyceride levels on plaque characteristics in patients with coronary artery disease.
    Int J Cardiol. 2022;348:134-139.
    PubMed     Abstract available


  134. XU X, Fam JM, Low AFH, Tan RS, et al
    Sex differences in assessing stenosis severity between physician visual assessment and quantitative coronary angiography.
    Int J Cardiol. 2022;348:9-14.
    PubMed     Abstract available


  135. ALFONSO F, Rivero F, Cortese B
    Excimer laser prior to drug-coated balloon treatment of in-stent restenosis.
    Int J Cardiol. 2022;348:47-49.
    PubMed    


  136. ORSINI E, Marzilli M, Zito GB, Carbone V, et al
    Clinical outcomes of newly diagnosed, stable angina patients managed according to current guidelines. The ARCA (Arca Registry for Chronic Angina) Registry: A prospective, observational, nationwide study.
    Int J Cardiol. 2022 Feb 1. pii: S0167-5273(22)00182.
    PubMed     Abstract available


    January 2022
  137. FU EL, Clase CM, Janse RJ, Lindholm B, et al
    Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00131.
    PubMed     Abstract available


  138. GROENLAND FTW, Neleman T, Kakar H, Scoccia A, et al
    Intravascular ultrasound-guided versus coronary angiography-guided percutaneous coronary intervention in patients with acute myocardial infarction: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Jan 15. pii: S0167-5273(22)00068.
    PubMed     Abstract available


  139. ADLAM D, Zarebinski M, Uren NG, Ptaszynski P, et al
    A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI.
    Int J Cardiol. 2022;347:1-7.
    PubMed     Abstract available


  140. PERFETTI M, Di Nicola M, Zimarino M
    Asimmetric uncertainties and account balance. Editorial to "Instantaneous wave-free ratio compared with fractional flow 2 reserve in PCI: A cost-minimization analysis".
    Int J Cardiol. 2022;347:19-20.
    PubMed    


  141. KHAN E, Lambrakis K, Nazir SA, Chuang A, et al
    Implementation of more sensitive cardiac troponin T assay in a state-wide health service.
    Int J Cardiol. 2022;347:66-72.
    PubMed     Abstract available


  142. MA P, Liu J, Hu Y, Zhou X, et al
    Histologic validation of stress cardiac magnetic resonance T1-mapping techniques for detection of coronary microvascular dysfunction in rabbits.
    Int J Cardiol. 2022;347:76-82.
    PubMed     Abstract available


  143. GUECKEL J, Puelacher C, Glarner N, Gualandro DM, et al
    Patient- and procedure-related factors in the pathophysiology of perioperative myocardial infarction/injury.
    Int J Cardiol. 2022 Jan 11. pii: S0167-5273(22)00062.
    PubMed     Abstract available


  144. WU Z, Cheng S, Wang S, Li W, et al
    C-MYC ameliorates ventricular remodeling of myocardial infarction rats via binding to the promoter of microRNA-29a-3p to facilitate TET2 expression.
    Int J Cardiol. 2022 Jan 8. pii: S0167-5273(22)00067.
    PubMed     Abstract available


  145. HU M, Lu Y, Wan S, Li B, et al
    Long-term outcomes in inferior ST-segment elevation myocardial infarction patients with right ventricular myocardial infarction.
    Int J Cardiol. 2022 Jan 5. pii: S0167-5273(22)00003.
    PubMed     Abstract available


  146. GIBSON CM, Mehta S, Ceschim MRS, Frauenfelder A, et al
    Evolution of single-lead ECG for STEMI detection using a deep learning approach.
    Int J Cardiol. 2022;346:47-52.
    PubMed     Abstract available


  147. FERRANNINI E, Marx N, Andreini D, Campi B, et al
    Mannose as a biomarker of coronary artery disease: Angiographic evidence and clinical significance.
    Int J Cardiol. 2022;346:86-92.
    PubMed     Abstract available


  148. GATTO L, Alfonso F, Paoletti G, Burzotta F, et al
    Relationship betweeen the amount and location of macrophages and clinical outcome: subanalysis of the CLIMA-study.
    Int J Cardiol. 2022;346:8-12.
    PubMed     Abstract available


    December 2021
  149. KUCHARSKA-NEWTON AM, Loop MS, Bullo M, Moore C, et al
    Use of troponins in the classification of myocardial infarction from electronic health records. The Atherosclerosis Risk in Communities (ARIC) Study.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02014.
    PubMed     Abstract available


  150. DE LUCA L, Cicala SD, D'Errigo P, Cerza F, et al
    Impact of age, gender and heart failure on mortality trends after acute myocardial infarction in Italy.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02015.
    PubMed     Abstract available


  151. ZEITZ C
    Relieving angina - interplay between gender, pathophysiology and medication efficacy.
    Int J Cardiol. 2021;345:20-21.
    PubMed    


  152. CESARO A, Gragnano F, Calabro P, Moscarella E, et al
    Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.
    Int J Cardiol. 2021;345:7-13.
    PubMed     Abstract available


  153. TAKAHASHI J, Shimokawa H, Yasuda S
    Usefulness of hybrid assessment for coronary functional abnormalities by non-invasive and invasive techniques.
    Int J Cardiol. 2021;345:24-25.
    PubMed    


  154. GALLI M, Franchi F
    Guided selection of antiplatelet therapy in acute coronary syndrome: Impact on outcomes and resource utilization.
    Int J Cardiol. 2021;345:36-38.
    PubMed    


  155. AHN JH, Ahn Y, Jeong MH, Kim JH, et al
    Optimal low-density lipoprotein cholesterol target level in Korean acute myocardial infarction patients (<70mg/dL vs. <55mg/dL): Based on Korea acute myocardial infarction registry-National Institute of Health.
    Int J Cardiol. 2021 Dec 15. pii: S0167-5273(21)02012.
    PubMed     Abstract available


  156. MEHTA PK, Quesada O, Al-Badri A, Fleg J, et al
    Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.
    Int J Cardiol. 2021 Dec 10. pii: S0167-5273(21)02005.
    PubMed     Abstract available


  157. YANDRAPALLI S, Malik AH, Namrata F, Pemmasani G, et al
    Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01976.
    PubMed     Abstract available


  158. ANANTHAKRISHNA R, Liang Z, Raman B, Moran JL, et al
    Long-term clinical outcomes in patients with a working diagnosis of myocardial infarction with non-obstructed coronary arteries (MINOCA) assessed by cardiovascular magnetic resonance imaging.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01979.
    PubMed     Abstract available


  159. LEMESLE G, Bauters C, Bonello L, Fauchier L, et al
    Management of antithrombotics in situations with a gap in evidence: A national French survey focusing on patients with coronary artery disease and atrial fibrillation.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01966.
    PubMed     Abstract available


  160. TSUJITA K
    Realistic detection of natural history of early coronary atherosclerosis: Best part of computed tomography-derived fractional flow reserve?
    Int J Cardiol. 2021;344:34-35.
    PubMed    


  161. BERNTORP K, Persson J, Koul SM, Patel MR, et al
    Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis.
    Int J Cardiol. 2021;344:54-59.
    PubMed     Abstract available


  162. RIJLAARSDAM-HERMSEN D, van Domburg RT, Deckers JW, Kuijpers D, et al
    Comparison of guidelines for diagnosing suspected stable angina and the additional value of the calcium score.
    Int J Cardiol. 2021;344:1-7.
    PubMed     Abstract available


    November 2021
  163. TANG Y, Liu S, Shi Y, He T, et al
    Association of blood pressure in the first-week of hospitalization and long-term mortality in patients with acute left ventricular myocardial infarction.
    Int J Cardiol. 2021 Nov 24. pii: S0167-5273(21)01861.
    PubMed     Abstract available


  164. MARCOS-GARCES V, Perez N, Gavara J, Lopez-Lereu MP, et al
    Risk score for early risk prediction by cardiac magnetic resonance after acute myocardial infarction.
    Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01866.
    PubMed     Abstract available


  165. GORIKI Y, Yoshioka G, Natsuaki M, Shinzato K, et al
    Simple risk-score model for in-hospital major bleeding based on multiple blood variables in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Nov 18. pii: S0167-5273(21)01862.
    PubMed     Abstract available


  166. HENG GE
    Is diastolic dysfunction a new windsock in the risk stratification of patients with coronary heart disease?
    Int J Cardiol. 2021 Nov 17. pii: S0167-5273(21)01853.
    PubMed    


  167. DESEIVE S, Orban M
    Choosing the right potent P2Y12-receptor inhibitor in East Asians with acute myocardial infarction and percutaneous coronary intervention - Editorial on Ticagrelor versus Prasugrel in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Nov 16. pii: S0167-5273(21)01848.
    PubMed    


  168. TANG LH, Harrison A, Skou ST, Doherty P, et al
    To what extent are comorbidity profiles associated with referral and uptake to cardiac rehabilitation.
    Int J Cardiol. 2021;343:85-91.
    PubMed     Abstract available


  169. DIXON LK, Di Tommaso E, Dimagli A, Sinha S, et al
    Impact of sex on outcomes after cardiac surgery: A systematic review and meta-analysis.
    Int J Cardiol. 2021;343:27-34.
    PubMed     Abstract available


  170. PYXARAS SA, Harmel EK
    Artificial intelligence for the assessment of coronary artery disease- The dawn of a new era?
    Int J Cardiol. 2021;343:3-4.
    PubMed    


  171. FENDER AC, Dobrev D
    Nitric oxide as a fragile switch between cardioprotection and cardiac injury.
    Int J Cardiol. 2021;343:102-103.
    PubMed    


  172. NAKAJIMA A, Subban V, Russo M, Bryniarski KL, et al
    Coronary plaque and clinical characteristics of South Asian (Indian) patients with acute coronary syndromes: An optical coherence tomography study.
    Int J Cardiol. 2021;343:171-179.
    PubMed     Abstract available


  173. TSUGU T, Tanaka K, Belsack D, Devos H, et al
    Impact of vascular morphology and plaque characteristics on computed tomography derived fractional flow reserve in early stage coronary artery disease.
    Int J Cardiol. 2021;343:187-193.
    PubMed     Abstract available


  174. JENSCH PJ, Stiermaier T, Reinstadler SJ, Feistritzer HJ, et al
    Prognostic relevance of peri-infarct zone measured by cardiovascular magnetic resonance in patients with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01785.
    PubMed     Abstract available


  175. BANG C, Lauridsen KG, Andersen CF, Lofgren B, et al
    Reply to the Letter to the Editor: "Is single troponin measurement truly safe enough to rule out myocardial infarction in early presenters?"
    Int J Cardiol. 2021 Nov 2. pii: S0167-5273(21)01761.
    PubMed    


  176. SOFI F, Dinu M, Reboldi G, Stracci F, et al
    Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Nov 2. pii: S0167-5273(21)01765.
    PubMed     Abstract available


  177. XU JJ, Cui J, Lin Q, Chen XY, et al
    Protection of the enhanced Nrf2 deacetylation and its downstream transcriptional activity by SIRT1 in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2021;342:82-93.
    PubMed     Abstract available


  178. TRAVERSE JH
    The coronary sinus reducer - Where modern technology meets old school physiology!
    Int J Cardiol. 2021;342:31-32.
    PubMed    


  179. COOK CM, Howard JP, Ahmad Y, Shun-Shin MJ, et al
    Comparing invasive hemodynamic responses in adenosine hyperemia versus physical exercise stress in chronic coronary syndromes.
    Int J Cardiol. 2021;342:7-14.
    PubMed     Abstract available


  180. LI KS, Bai Y, Li J, Li SL, et al
    LncRNA HCP5 in hBMSC-derived exosomes alleviates myocardial ischemia reperfusion injury by sponging miR-497 to activate IGF1/PI3K/AKT pathway.
    Int J Cardiol. 2021;342:72-81.
    PubMed     Abstract available


    October 2021
  181. HAN X, Chen Z, Wang Y, Zhang J, et al
    Prognostic significance of QRS distortion and frontal QRS-T angle in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2021 Oct 26. pii: S0167-5273(21)01693.
    PubMed     Abstract available


  182. BOUISSET F, Deney A, Ferrieres J, Panagides V, et al
    Mechanical complications in ST-elevation myocardial infarction: The impact of pre-hospital delay.
    Int J Cardiol. 2021 Oct 23. pii: S0167-5273(21)01574.
    PubMed     Abstract available


  183. ONO M, Kawashima H, Hara H, Mancone M, et al
    Impact of major infections on 10-year mortality after revascularization in patients with complex coronary artery disease.
    Int J Cardiol. 2021;341:9-12.
    PubMed     Abstract available


  184. WEBB CM, Collins P
    Medical management of anginal symptoms in women with stable angina pectoris: A systematic review of randomised controlled trials.
    Int J Cardiol. 2021;341:1-8.
    PubMed     Abstract available


  185. GIOVANNINI M, Koniari I, Mori F, Barni S, et al
    Kounis syndrome: Towards a new classification.
    Int J Cardiol. 2021;341:13-14.
    PubMed    


  186. CHALIKIAS G, Tziakas DN
    Triggering receptor expressing on myeloid cells (TREM)-1 and acute myocardial infarction: An association vs. causality conundrum.
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01507.
    PubMed    


  187. CHIANG CH, Chiang CH, Chiang CH
    Is single troponin measurement truly safe enough to rule out myocardial infarction in early presenters?
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01388.
    PubMed    


  188. PARK S, Kim YG, Ann SH, Park HW, et al
    Ticagrelor versus prasugrel in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Oct 4. pii: S0167-5273(21)01505.
    PubMed     Abstract available


  189. ARCHILLETTI F, Zimarino M
    Intravascular ultrasound for in-stent restenosis: A problem well stated is half-solved.
    Int J Cardiol. 2021;340:22-23.
    PubMed    


  190. GUO Y, Li Q, Xuan YT, Wu WJ, et al
    Exercise-induced late preconditioning in mice is triggered by eNOS-dependent generation of nitric oxide and activation of PKCepsilon and is mediated by increased iNOS activity.
    Int J Cardiol. 2021;340:68-78.
    PubMed     Abstract available


  191. YONG ASC, Pargaonkar VS, Wong CCY, Javadzdegan A, et al
    Abnormal shear stress and residence time are associated with proximal coronary atheroma in the presence of myocardial bridging.
    Int J Cardiol. 2021;340:7-13.
    PubMed     Abstract available


  192. SHLOFMITZ E, Torguson R, Zhang C, Mintz GS, et al
    Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study).
    Int J Cardiol. 2021;340:17-21.
    PubMed     Abstract available


    September 2021
  193. LENG WX, Yang YJ
    Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Sep 25. pii: S0167-5273(21)01484.
    PubMed    


  194. COSENTINO N, Resta ML, Somaschini A, Campodonico J, et al
    Acute kidney injury and in-hospital mortality in patients with ST-elevation myocardial infarction of different age groups.
    Int J Cardiol. 2021 Sep 17. pii: S0167-5273(21)01383.
    PubMed     Abstract available


  195. AIT-OUFELLA H, Yu M, Kotti S, Georges A, et al
    Plasma and genetic determinants of soluble TREM-1 and major adverse cardiovascular events in a prospective cohort of acute myocardial infarction patients. Results from the FAST-MI 2010 study.
    Int J Cardiol. 2021 Sep 15. pii: S0167-5273(21)01379.
    PubMed     Abstract available


  196. TEBALDI M, Marrone A
    The management of patients with acute myocardial infarction: route to tailored therapy.
    Int J Cardiol. 2021 Sep 15. pii: S0167-5273(21)01382.
    PubMed    


  197. REINDL M, Lechner I, Reinstadler SJ, Metzler B, et al
    Transient STEMI - No STEMI at all?
    Int J Cardiol. 2021;339:12-13.
    PubMed    


  198. ISHIHARA T, Dohi T, Nakamura D, Kikuchi A, et al
    Impact of in-stent tissue characteristics on excimer laser coronary angioplasty prior to drug-coated balloon treatment.
    Int J Cardiol. 2021;339:28-32.
    PubMed     Abstract available


  199. LIU H, Bi K, Hu Y
    Targeting vimentin in coronary artery disease.
    Int J Cardiol. 2021;339:144.
    PubMed    


  200. JANG WJ, Park IH, Yang JH, Chun WJ, et al
    Association between polyvascular disease and clinical outcomes in patients with cardiogenic shock: Results from the RESCUE registry.
    Int J Cardiol. 2021;339:70-74.
    PubMed     Abstract available


  201. ANGELINI P, Uribe C
    Where's the beef in anomalous coronary artery origin from an opposite aortic sinus?
    Int J Cardiol. 2021;339:45-46.
    PubMed    


  202. ZORZI A, Brunetti G, Cardaioli F, D'Arcangelo F, et al
    Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation.
    Int J Cardiol. 2021;339:219-224.
    PubMed     Abstract available


  203. AL-RUBAISH AM, Al-Muhanna FA, Alshehri AM, Al-Mansori MA, et al
    Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients.
    Int J Cardiol. 2021 Sep 10. pii: S0167-5273(21)01319.
    PubMed     Abstract available


  204. ANDERSEN P, Kragholm K, Torp-Pedersen C, Jensen SE, et al
    The impact of peripheral artery disease on major adverse cardiovascular events following myocardial infarction.
    Int J Cardiol. 2021 Sep 6. pii: S0167-5273(21)01321.
    PubMed     Abstract available


  205. MAANIITTY T, Stenstrom I, Saraste A, Knuuti J, et al
    Extensive and balanced reduction of myocardial blood flow in patients with suspected obstructive coronary artery disease: 15O-water PET study.
    Int J Cardiol. 2021;338:1-7.
    PubMed     Abstract available


  206. LAHU S, Ndrepepa G, Gewalt S, Schupke S, et al
    Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromes.
    Int J Cardiol. 2021;338:8-13.
    PubMed     Abstract available


  207. GUO Z, Zhao M, Jia G, Ma R, et al
    LncRNA PART1 alleviated myocardial ischemia/reperfusion injury via suppressing miR-503-5p/BIRC5 mediated mitochondrial apoptosis.
    Int J Cardiol. 2021;338:176-184.
    PubMed     Abstract available


  208. REINHOLD J, Papadopoulou C, Baral R, Vassiliou VS, et al
    Reply to commentary on the article entitled "Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis".
    Int J Cardiol. 2021;338:41.
    PubMed    


  209. ZHENG X, Li J, Fan Q, Zhao X, et al
    Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca(2+) overload via the microRNA-346-3p/CaMKIId axis.
    Int J Cardiol. 2021;338:185-195.
    PubMed     Abstract available


    August 2021
  210. PICARD F, Bhatt DL, Ducrocq G, Ohman EM, et al
    Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) reg
    Int J Cardiol. 2021 Aug 24. pii: S0167-5273(21)01297.
    PubMed     Abstract available


  211. FRANGOGIANNIS NG
    Platelet-derived growth factor (PDGF) therapy in myocardial infarction: Challenges and opportunities.
    Int J Cardiol. 2021 Aug 18. pii: S0167-5273(21)01232.
    PubMed    


  212. WERNER GS, Lorenz S, Yaginuma K, Koch M, et al
    A prospective study on the incidence of contrast-associated acute kidney injury after recanalization of chronic total coronary occlusions with contemporary interventional techniques.
    Int J Cardiol. 2021;337:38-43.
    PubMed     Abstract available


  213. BHATT DL, Kaski JC, Delaney S, Alasnag M, et al
    Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention.
    Int J Cardiol. 2021;337:1-8.
    PubMed     Abstract available


  214. HEGGIE R, Briggs A, Stanley B, Good R, et al
    Stratified medicine using invasive coronary function testing in angina: A cost-effectiveness analysis of the British Heart Foundation CorMicA trial.
    Int J Cardiol. 2021;337:44-51.
    PubMed     Abstract available


  215. ANDERSEN CF, Bang C, Lauridsen KG, Frederiksen CA, et al
    Single troponin measurement to rule-out acute myocardial infarction in early presenters.
    Int J Cardiol. 2021 Aug 12. pii: S0167-5273(21)01215.
    PubMed     Abstract available


  216. ZUIN M, Rigatelli G
    Thrombus straddling a patent foramen ovale: Also a myocardial infarction matter?
    Int J Cardiol. 2021 Aug 7. pii: S0167-5273(21)01206.
    PubMed    


  217. GOLI S, Sakita FM, Kweka GL, Tarimo TG, et al
    Thirty-day outcomes and predictors of mortality following acute myocardial infarction in northern Tanzania: A prospective observational cohort study.
    Int J Cardiol. 2021 Aug 5. pii: S0167-5273(21)01212.
    PubMed     Abstract available


  218. PELLICCIA F, Pepine CJ, Berry C, Camici PG, et al
    The role of a comprehensive two-step diagnostic evaluation to unravel the pathophysiology of MINOCA: A review.
    Int J Cardiol. 2021;336:1-7.
    PubMed     Abstract available


  219. KARACSONYI J, Alaswad K, Choi JW, Vemmou E, et al
    Laser for balloon uncrossable and undilatable chronic total occlusion interventions.
    Int J Cardiol. 2021;336:33-37.
    PubMed     Abstract available


  220. DEIDDA M, Noto A, Cadeddu Dessalvi C, Andreini D, et al
    Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 x 2 phenotypic CAPIRE study.
    Int J Cardiol. 2021;336:14-21.
    PubMed     Abstract available


  221. DING Q
    Comment on the article entitled "Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis".
    Int J Cardiol. 2021;336:32.
    PubMed    


  222. G TOTH G, Johnson NP, Wijns W, Toth B, et al
    Revascularization decisions in patients with chronic coronary syndromes: Results of the second International Survey on Interventional Strategy (ISIS-2).
    Int J Cardiol. 2021;336:38-44.
    PubMed     Abstract available


  223. GIANNINI F, Ponticelli F, Guarracini S, Tzanis G, et al
    Reply to: "The importance of evaluating coronary sinus blood flow during the coronary sinus reducer treatment".
    Int J Cardiol. 2021;336:46.
    PubMed    


    July 2021
  224. JAMAL J, O'Loughlin A, French JK
    A fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Jul 31. pii: S0167-5273(21)01210.
    PubMed    


  225. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
    Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
    Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
    PubMed     Abstract available


  226. AIMO A, Panichella G, Barison A, Maffei S, et al
    Sex-related differences in ventricular remodeling after myocardial infarction.
    Int J Cardiol. 2021 Jul 24. pii: S0167-5273(21)01181.
    PubMed     Abstract available


  227. JACOBSEN MR, Engstrom T, Torp-Pedersen C, Gislason G, et al
    Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2021 Jul 23. pii: S0167-5273(21)01192.
    PubMed     Abstract available


  228. MONTONE RA, La Vecchia G
    Interplay between inflammation and microvascular obstruction in ST-elevation myocardial infarction: The importance of velocity.
    Int J Cardiol. 2021 Jul 23. pii: S0167-5273(21)01186.
    PubMed    


  229. MONTALTO C, Kotronias RA, Marin F, Terentes-Printzios D, et al
    Pre-procedural ATI score (age-thrombus burden-index of microcirculatory resistance) predicts long-term clinical outcomes in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Int J Cardiol. 2021 Jul 23. pii: S0167-5273(21)01185.
    PubMed     Abstract available


  230. PEPE M, Frati G, Biondi-Zoccai G, Corcione N, et al
    Direct and indirect effects of COVID-19 on acute coronary syndromes: Can we pick the worst?
    Int J Cardiol. 2021;335:19-20.
    PubMed    


  231. WANG H, Xia Y, Sun Z
    Dexmedetomidine: A potential therapy for myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2021;335:104.
    PubMed    


  232. OZLEK B, Ozlek E, Gokcek A
    Reply to the letter: "Kounis syndrome: Towards a new classification".
    Int J Cardiol. 2021;335:25.
    PubMed    


  233. MINANA G, Nunez J, Marcos-Garces V, Gavara J, et al
    Long-term prognostic implications of revascularization in patients with known or suspected chronic coronary syndromes without ischemia in vasodilator stress cardiovascular magnetic resonance.
    Int J Cardiol. 2021;335:15-18.
    PubMed     Abstract available


  234. NG MY, Chan KYE, Chan CWS
    Cardiac magnetic resonance stress and rest perfusion with T1 mapping: Is it ready to assess for ischaemic heart disease?
    Int J Cardiol. 2021;335:137-138.
    PubMed    


  235. SILVERIO A, Galasso G, De Luca G
    Consolidating the value of fondaparinux for current treatment of non-ST-elevation acute coronary syndromes.
    Int J Cardiol. 2021;335:21-23.
    PubMed    


  236. BENJAMINS JW, Yeung MW, Maaniitty T, Saraste A, et al
    Improving patient identification for advanced cardiac imaging through machine learning-integration of clinical and coronary CT angiography data.
    Int J Cardiol. 2021;335:130-136.
    PubMed     Abstract available


  237. TARUYA A, Nakajima Y, Tanaka A, Kashiwagi M, et al
    Cancer-related vulnerable lesions in patients with stable coronary artery disease.
    Int J Cardiol. 2021;335:1-6.
    PubMed     Abstract available


  238. SAMBOLA A, Soriano-Colome T
    Sex disparity in prognosis and costs of type 2 myocardial infarction.
    Int J Cardiol. 2021 Jul 14. pii: S0167-5273(21)01158.
    PubMed    


  239. RASHID FN, Clayton ZE, Ogawa M, Perdomo J, et al
    Platelet derived growth factor-A (Pdgf-a) gene transfer modulates scar composition and improves left ventricular function after myocardial infarction.
    Int J Cardiol. 2021 Jul 12. pii: S0167-5273(21)01166.
    PubMed     Abstract available


  240. ONG P, Sechtem U
    Diagnostic work-up of patients with myocardial infarction with unobstructed coronary arteries (MINOCA) - Practical considerations.
    Int J Cardiol. 2021 Jul 12. pii: S0167-5273(21)01159.
    PubMed    


  241. SHAH P, Jimenez-Ruiz A, Gibson A, Vargas-Gonzalez JC, et al
    Association between acute myocardial infarction and death in 386 patients with a thrombus straddling a patent foramen ovale.
    Int J Cardiol. 2021 Jul 7. pii: S0167-5273(21)01101.
    PubMed     Abstract available


  242. LODI RIZZINI M, Nagumo S, Gallo D, Sonck J, et al
    Mismatch between morphological and functional assessment of the length of coronary artery disease.
    Int J Cardiol. 2021;334:1-9.
    PubMed     Abstract available


  243. XIONG B, Wang Y, Liu Y, Wu C, et al
    The circulating LncRNA SNHG15/miR-346 axis may be a potential biomarker of cardiomyocyte apoptosis during myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2021;334:30.
    PubMed    


  244. XU Y, Yu L, Shen C, Lu Z, et al
    Prevalence and disease features of myocardial ischemia with non-obstructive coronary arteries: Insights from a dynamic CT myocardial perfusion imaging study.
    Int J Cardiol. 2021;334:142-147.
    PubMed     Abstract available


  245. GROENLAND EH, Bots ML, Asselbergs FW, de Borst GJ, et al
    Apparent treatment resistant hypertension and the risk of recurrent cardiovascular events and mortality in patients with established vascular disease.
    Int J Cardiol. 2021;334:135-141.
    PubMed     Abstract available


  246. DENG J
    Advanced research on the regulated necrosis mechanism in myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2021;334:97-101.
    PubMed     Abstract available


  247. VERDOIA M, Barbieri L, De Luca G
    Antiplatelet therapy in ACS elderly patients: Another piece of this intriguing puzzle.
    Int J Cardiol. 2021;334:28-29.
    PubMed    


  248. XIE MY, Hou LJ
    Dexmedetomidine down-regulates lncRNA MALAT1 to attenuate myocardial ischemia reperfusion-induced injury by increasing miR-346.
    Int J Cardiol. 2021;334:104.
    PubMed    


  249. SUADES R
    miRNA-346-3p/CaMKIId axis: In'DEX'ing a new pharmacological strategy for cardioprotection.
    Int J Cardiol. 2021;334:102-103.
    PubMed    


  250. DOAN TT, Molossi S, Sachdeva S, Wilkinson JC, et al
    Dobutamine stress cardiac MRI is safe and feasible in pediatric patients with anomalous aortic origin of a coronary artery (AAOCA).
    Int J Cardiol. 2021;334:42-48.
    PubMed     Abstract available


  251. CLAASSENS DMF, Gimbel ME, Bergmeijer TO, Vos GJA, et al
    Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients.
    Int J Cardiol. 2021;334:10-17.
    PubMed     Abstract available


  252. KOMAKI S, Ishii M, Ikebe S, Kaichi R, et al
    Association between coronary artery calcium score and stent expansion in percutaneous coronary intervention.
    Int J Cardiol. 2021;334:31-36.
    PubMed     Abstract available


  253. FLORIAN A
    Diastolic dysfunction in women with ischemia and non-obstructive coronary arteries (INOCA) - Could non-invasive imaging reveal the missing piece of the puzzle?
    Int J Cardiol. 2021;334:21-23.
    PubMed    


  254. DAMMAN P, Elias-Smale SE
    How is angina related to coronary microvascular dysfunction? A tip of the veil lifted.
    Int J Cardiol. 2021;334:26-27.
    PubMed    


    June 2021
  255. LI Y, Si S, Hou L, Yuan T, et al
    Causal effect of sex hormone-binding globulin and testosterone on coronary heart disease: A multivariable and network Mendelian randomization analysis.
    Int J Cardiol. 2021 Jun 25. pii: S0167-5273(21)01035.
    PubMed     Abstract available


  256. VERDOIA M, Brancati MF, Solda PL
    Commentary to: "Prognosis of spontaneous myocardial infarction and various definitions of periprocedural myocardial infarction in patients who underwent percutaneous coronary intervention".
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)00983.
    PubMed    


  257. HOLZKNECHT M, Tiller C, Reindl M, Lechner I, et al
    C-reactive protein velocity predicts microvascular pathology after acute ST-elevation myocardial infarction.
    Int J Cardiol. 2021 Jun 18. pii: S0167-5273(21)00982.
    PubMed     Abstract available


  258. KONST RE, Damman P, Pellegrini D, Hartzema-Meijer MJ, et al
    Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm.
    Int J Cardiol. 2021;333:14-20.
    PubMed     Abstract available


  259. POLZIN A, Helten C, Dannenberg L, Muller T, et al
    Sphingosine-1-phosphate: A mediator of the ARB-MI paradox?
    Int J Cardiol. 2021;333:40-42.
    PubMed     Abstract available


  260. DI SERAFINO L, Mangiacapra F, Pyxaras S, Morisco C, et al
    Relationship between peripheral arterial reactive hyperemia and the index of myocardial resistance in patients undergoing invasive coronary angiography.
    Int J Cardiol. 2021;333:8-13.
    PubMed     Abstract available


  261. SUPPOGU N, Wei J, Quesada O, Shufelt C, et al
    Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease.
    Int J Cardiol. 2021;333:35-39.
    PubMed     Abstract available


  262. STEINER J, Kerschl M, Erbay A, Abdelwahed YS, et al
    Impact of renal function on outcomes of patients with cardiac troponin elevation and non-obstructive coronary arteries.
    Int J Cardiol. 2021;333:29-34.
    PubMed     Abstract available


  263. BUCKLEY JP, Mylotte D, McEvoy JW
    Platelets and poppies: Do morphine and fentanyl differ?
    Int J Cardiol. 2021;333:43-44.
    PubMed    


  264. NISHI T, Yamashita R, Imura S, Tateishi K, et al
    Deep learning-based intravascular ultrasound segmentation for the assessment of coronary artery disease.
    Int J Cardiol. 2021;333:55-59.
    PubMed     Abstract available


  265. HOSHINO M, Zhang J, Sugiyama T, Yang S, et al
    Prognostic value of pericoronary inflammation and unsupervised machine-learning-defined phenotypic clustering of CT angiographic findings.
    Int J Cardiol. 2021;333:226-232.
    PubMed     Abstract available


  266. ANDREOTTI F, Crea F, Patti G, Shoulders CC, et al
    Family history in first degree relatives of patients with premature cardiovascular disease.
    Int J Cardiol. 2021;333:215-218.
    PubMed     Abstract available


  267. YANG C, Yang J, Fan Z, Yang J, et al
    ECs-derived exosomes: A novel therapeutic target for myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2021;333:51.
    PubMed    


  268. AIMO A, Pelliccia F, Panichella G, Vergaro G, et al
    Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity.
    Int J Cardiol. 2021;333:45-50.
    PubMed     Abstract available


  269. SACHDEVA S, Desai R, Singh S, Kumar G, et al
    Work from home culture and acute cardiovascular events: A bidirectional conundrum yet to be resolved!
    Int J Cardiol. 2021;333:250.
    PubMed    


  270. LI J, Tong Y, Zhou Y, Han Z, et al
    LncRNA KCNQ1OT1 as a miR-26a-5p sponge regulates ATG12-mediated cardiomyocyte autophagy and aggravates myocardial infarction.
    Int J Cardiol. 2021 Jun 2. pii: S0167-5273(21)00910.
    PubMed     Abstract available


  271. D'ASCENZO F, De Filippo O, Borin A, Barbieri L, et al
    Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry.
    Int J Cardiol. 2021;332:227-234.
    PubMed     Abstract available


  272. VERWEIJ L, Jorstad HT, Minneboo M, Ter Riet G, et al
    The influence of partners on successful lifestyle modification in patients with coronary artery disease.
    Int J Cardiol. 2021;332:195-201.
    PubMed     Abstract available


  273. AKSIT E, Altay S, Altun A
    The importance of evaluating coronary sinus blood flow during the coronary sinus reducer treatment.
    Int J Cardiol. 2021;332:38.
    PubMed    


  274. SCIAGRA R, Di Paolantonio M, Rubino F, Arnone A, et al
    The STREAM trial: Great expectations for getting clearness in an opaque disease.
    Int J Cardiol. 2021;332:140-141.
    PubMed    


  275. CHAO CJ, Shanbhag A, Chiang CC, Girardo ME, et al
    Baseline thrombocytopenia in acute coronary syndrome: The lower, the worse.
    Int J Cardiol. 2021;332:1-7.
    PubMed     Abstract available


  276. XIE Z, Zhu J, Li W, Liu L, et al
    Relationship of epicardial fat volume with coronary plaque characteristics, coronary artery calcification score, coronary stenosis, and CT-FFR for lesion-specific ischemia in patients with known or suspected coronary artery disease.
    Int J Cardiol. 2021;332:8-14.
    PubMed     Abstract available


  277. SHYU KG, Wang BW, Lin CM
    Reply to the letter to the Editor "ECs-derived exosomes: A novel therapeutic target for myocardial ischemia-reperfusion injury".
    Int J Cardiol. 2021;332:39.
    PubMed    


  278. TIAN B, Li T, Wang M
    MicroRNA-19a might be a new potential therapeutic target in the treatment of coronary artery disease.
    Int J Cardiol. 2021;332:164.
    PubMed    


  279. TESCHE C, Ellis L, Brandt V
    Non-invasive plaque morphology-based FFR assessment: A new approach to predict ischemic coronary artery disease?
    Int J Cardiol. 2021;332:223-224.
    PubMed    


  280. ALMENDRO-DELIA M, Izquierdo-Bajo A, Madrona-Jimenez L, Blanco-Ponce E, et al
    Fondaparinux versus enoxaparin in the contemporary management of non-ST-elevation acute coronary syndromes. Insights from a multicenter registry.
    Int J Cardiol. 2021;332:29-34.
    PubMed     Abstract available


    May 2021
  281. ARISS RW, Elzanaty AM, Minhas AMK, Nazir S, et al
    Sex-based differences in clinical outcomes and resource utilization of type 2 myocardial infarction.
    Int J Cardiol. 2021 May 28. pii: S0167-5273(21)00900.
    PubMed     Abstract available


  282. JANSSENS GN, Lemkes JS, van der Hoeven NW, van Leeuwen MAH, et al
    Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome.
    Int J Cardiol. 2021 May 15. pii: S0167-5273(21)00830.
    PubMed     Abstract available


  283. OTTOSSON F, Emami Khoonsari P, Gerl MJ, Simons K, et al
    A plasma lipid signature predicts incident coronary artery disease.
    Int J Cardiol. 2021;331:249-254.
    PubMed     Abstract available


  284. SAMUEL TJ, Wei J, Sharif B, Tamarappoo BK, et al
    Diastolic dysfunction in women with ischemia and no obstructive coronary artery disease: Mechanistic insight from magnetic resonance imaging.
    Int J Cardiol. 2021;331:1-7.
    PubMed     Abstract available


  285. ALMUKDAD S, Elewa H, Arafa S, Al-Badriyeh D, et al
    Short- and long-term cost-effectiveness analysis of CYP2C19 genotype-guided therapy, universal clopidogrel, versus universal ticagrelor in post-percutaneous coronary intervention patients in Qatar.
    Int J Cardiol. 2021;331:27-34.
    PubMed     Abstract available


  286. SEITZ A, Ong P
    Coexisting microvascular dysfunction in patients with diffuse epicardial coronary spasm: A novel piece of the coronary vasomotor disorder puzzle.
    Int J Cardiol. 2021;331:12-13.
    PubMed    


  287. SCHULZ S, Reichert S, Grollmitz J, Friebe L, et al
    The role of Saccharibacteria (TM7) in the subginival microbiome as a predictor for secondary cardiovascular events.
    Int J Cardiol. 2021;331:255-261.
    PubMed     Abstract available


  288. FABRIS E, Bhatt DL
    Variation in treatment strategy for NSTEMI: A complex phenomenon.
    Int J Cardiol. 2021;331:14-16.
    PubMed    


  289. VARGA-SZEMES A, Schoepf UJ, Maurovich-Horvat P, Wang R, et al
    Coronary plaque assessment of Vasodilative capacity by CT angiography effectively estimates fractional flow reserve.
    Int J Cardiol. 2021;331:307-315.
    PubMed     Abstract available


  290. HAITJEMA S, Hoefer IE
    Towards affordable diagnostics and risk management in cardiology: As simple as counting cells?
    Int J Cardiol. 2021;331:206-207.
    PubMed    


  291. ECCLESTON D
    Anti-thrombotic therapy for medically managed patients after non-ST segment elevation acute coronary syndromes: Balancing the scales of ischaemic and bleeding risk.
    Int J Cardiol. 2021;331:10-11.
    PubMed    


  292. VERDOIA M, De Luca G
    Comments on "Sex differences in distribution, management and outcomes of combined ischemic bleeding risk following acute coronary syndrome".
    Int J Cardiol. 2021;331:8-9.
    PubMed    


  293. XIE H, Mao Y, Wang M
    Tackling PTEN induced putative kinase 1 in angiotensin II-induced myocardial injury.
    Int J Cardiol. 2021;331:211.
    PubMed    


  294. REINDL M, Reinstadler SJ
    E-wave propagation index (EPI) - A promising echocardiographic marker to improve left ventricular thrombus detection after STEMI?
    Int J Cardiol. 2021;331:331-332.
    PubMed    


  295. BETTINK S, Lochel M, Peters D, Haider W, et al
    Efficacy and safety of a magnesium stearate paclitaxel coated balloon catheter in the porcine coronary model.
    Int J Cardiol. 2021;331:46-56.
    PubMed     Abstract available


  296. MARTINSSON A, Nielsen SJ, Bjorklund E, Pivodic A, et al
    Renin-angiotensin system inhibition and outcome after coronary artery bypass grafting: A population-based study from the SWEDEHEART registry.
    Int J Cardiol. 2021;331:40-45.
    PubMed     Abstract available


  297. XU A, Wang Y, Xiong B, Liu Y, et al
    LncRNA XIST may exert a profibrotic role via sponging miR-133a through SOCS2-activated autophagy in myocardial infarction.
    Int J Cardiol. 2021 May 6. pii: S0167-5273(21)00822.
    PubMed    


  298. ULANDER L, Tolppanen H, Hartman O, Rissanen TT, et al
    Hydroxychloroquine reduces interleukin-6 levels after myocardial infarction: The randomized, double-blind, placebo-controlled OXI pilot trial.
    Int J Cardiol. 2021 May 4. pii: S0167-5273(21)00805.
    PubMed     Abstract available


  299. MIRO O, Llorens P, Jimenez S, Pinera P, et al
    Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2.
    Int J Cardiol. 2021;330:268-272.
    PubMed    


  300. SANTOS-PARDO I, Lagerqvist B, Ritsinger V, Witt N, et al
    Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational study.
    Int J Cardiol. 2021;330:23-29.
    PubMed     Abstract available


  301. SENGUTTUVAN NB, Suman F, Paneerselvam T, Malepati B, et al
    Comparison of the effect of Morphine and Fentanyl in patients with acute coronary syndrome receiving Ticagrelor - The COMET (Comparison Morphine, Fentayl and Ticagrelor) randomized controlled trial.
    Int J Cardiol. 2021;330:1-6.
    PubMed     Abstract available


  302. ASLANGER EK, Meyers HP, Bracey A, Smith SW, et al
    The STEMI/NonSTEMI Dichotomy needs to be replaced by Occlusion MI vs. Non-Occlusion MI.
    Int J Cardiol. 2021;330:15.
    PubMed    


  303. DEMIR OM, Schrieken C, Curio J, Rahman H, et al
    Behavioural determinants impacting the adoption rate of coronary physiology.
    Int J Cardiol. 2021;330:12-14.
    PubMed     Abstract available


  304. SCHERRENBERG M, Janssen J, Lauwers A, Schreurs I, et al
    Is there an optimal dose of cardiac rehabilitation in coronary artery disease patients?
    Int J Cardiol. 2021;330:7-11.
    PubMed     Abstract available


  305. FUNAYAMA N, Kayanuma K, Sunaga D, Yamamoto T, et al
    Serial assessment of de novo coronary lesions after drug-coated balloon treatment analyzed by intravascular ultrasound: A comparison between acute coronary syndrome and stable angina pectoris.
    Int J Cardiol. 2021;330:35-40.
    PubMed     Abstract available


    April 2021
  306. IGLESIAS JF, Muller O, Losdat S, Roffi M, et al
    Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment-elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial.
    Int J Cardiol. 2021 Apr 19. pii: S0167-5273(21)00670.
    PubMed     Abstract available


  307. VERSACI F, Gaspardone A, Danesi A, Ferranti F, et al
    Interplay between COVID-19, pollution, and weather features on changes in the incidence of acute coronary syndromes in early 2020.
    Int J Cardiol. 2021;329:251-259.
    PubMed     Abstract available


  308. HARTFORD M, Herlitz H, Perers E, Karlsson T, et al
    Plasma renin activity has a complex prognostic role in patients with acute coronary syndromes.
    Int J Cardiol. 2021;329:198-204.
    PubMed     Abstract available


  309. PARCO C, Brockmeyer M, Kosejian L, Quade J, et al
    Modern NCDR and ACTION risk models outperform the GRACE model for prediction of in-hospital mortality in acute coronary syndrome in a German cohort.
    Int J Cardiol. 2021;329:28-35.
    PubMed     Abstract available


  310. DEKKER M, Waissi F, Bank IEM, Isgum I, et al
    The prognostic value of automated coronary calcium derived by a deep learning approach on non-ECG gated CT images from (82)Rb-PET/CT myocardial perfusion imaging.
    Int J Cardiol. 2021;329:9-15.
    PubMed     Abstract available


  311. PENG Y
    Reply to renal insufficiency and outcomes in patients with acute coronary syndrome.
    Int J Cardiol. 2021;329:49.
    PubMed    


  312. SAMBOLA A, Soriano-Colome T
    A sex paradox in clinical outcomes following complex percutaneous intervention. Treatment bias, biology or both?
    Int J Cardiol. 2021;329:77-78.
    PubMed    


  313. MOHAMED MO, Rashid M, Timmis A, Clarke S, et al
    Sex differences in distribution, management and outcomes of combined ischemic-bleeding risk following acute coronary syndrome.
    Int J Cardiol. 2021;329:16-22.
    PubMed     Abstract available


  314. LEE J, Park DW
    Revascularization or medical therapy for stable coronary artery disease: To do or not to do, that is the question.
    Int J Cardiol. 2021;329:46-47.
    PubMed    


  315. CAI Q, Gao ML, Huang LS, Chen HS, et al
    MALAT1/miRNA-203/Wnt5a: A potential mechanism for regulating coronary artery disease.
    Int J Cardiol. 2021;329:48.
    PubMed    


  316. NICOLAS J, Claessen BE, Cao D, Chiarito M, et al
    A sex paradox in clinical outcomes following complex percutaneous coronary intervention.
    Int J Cardiol. 2021;329:67-73.
    PubMed     Abstract available


  317. FEDOROWSKI A, Erlinge D
    How much is good enough? Insights from myocardial infarction incidence during COVID-19 pandemic.
    Int J Cardiol. 2021 Apr 12. pii: S0167-5273(21)00656.
    PubMed    


  318. HUANG SF, Ye WC
    LncRNA MALAT1 facilitated the progression of myocardial infarction by sponging miR-26b.
    Int J Cardiol. 2021 Apr 10. pii: S0167-5273(21)00652.
    PubMed    


  319. HOCHHOLZER W, Valina CM
    Antiplatelet therapy for STEMI: Hit it hard and early?
    Int J Cardiol. 2021;328:61-62.
    PubMed    


  320. HUANG S, Zeng Z, Sun Y, Cai Y, et al
    Association study of hsa_circ_0001946, hsa-miR-7-5p and PARP1 in coronary atherosclerotic heart disease.
    Int J Cardiol. 2021;328:1-7.
    PubMed     Abstract available


  321. REINHOLD J, Papadopoulou C, Baral R, Vassiliou VS, et al
    Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis.
    Int J Cardiol. 2021;328:46-54.
    PubMed     Abstract available


  322. YOUSIF N, Niederseer D, Davies A, El Issa M, et al
    Impact of malignancy on clinical outcomes in patients with acute coronary syndromes.
    Int J Cardiol. 2021;328:8-13.
    PubMed     Abstract available


  323. AHMAD A, Corban MT, Lerman A
    Contrast fractional flow reserve vs adenosine fractional flow reserve: The impact of discordant results.
    Int J Cardiol. 2021;328:59-60.
    PubMed    


  324. ORBAN M, Ulrich S, Dischl D, von Samson-Himmelstjerna P, et al
    Cardiac allograft vasculopathy: Differences of absolute and relative intimal hyperplasia in children versus adults in optical coherence tomography.
    Int J Cardiol. 2021;328:227-234.
    PubMed     Abstract available


  325. SUGISAWA J, Matsumoto Y, Takeuchi M, Suda A, et al
    Beneficial effects of exercise training on physical performance in patients with vasospastic angina.
    Int J Cardiol. 2021;328:14-21.
    PubMed     Abstract available


  326. JEFFRIES A, Costello B, Corkill W, Varghese S, et al
    Prognostic value of coronary artery calcium scoring and computed tomography coronary angiography in remote Indigenous and non-Indigenous Australians.
    Int J Cardiol. 2021;328:241-246.
    PubMed     Abstract available


  327. COHEN ARAZI H, Chirino D, Costabel JP, Pulmari CA, et al
    Leuko-platelet index predicts thrombotic events in patients with acute coronary syndrome.
    Int J Cardiol. 2021;328:29-34.
    PubMed     Abstract available


  328. MONTALTO C, Crimi G, Morici N, Piatti L, et al
    Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: External validation of the PRECISE-DAPT and PARIS scores.
    Int J Cardiol. 2021;328:22-28.
    PubMed     Abstract available


  329. EARLE NJ, Poppe KK, Rolleston A, Devlin G, et al
    Outcomes for working age patients after first-time acute coronary syndrome - ANZACS-QI 35.
    Int J Cardiol. 2021;328:55-58.
    PubMed     Abstract available


  330. TAVENIER AH, Hermanides RS, Fabris E, Angiolillo DJ, et al
    Bridging the gap: Current and future insights for improving suboptimal platelet inhibition in STEMI.
    Int J Cardiol. 2021;328:40-45.
    PubMed     Abstract available


    March 2021
  331. COMELLA A, Michail M, Chan J, Cameron JD, et al
    Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study.
    Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00566.
    PubMed     Abstract available


  332. ROGNONI A, D'Ascenzo F, Solli M, Mennuni MG, et al
    Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy.
    Int J Cardiol. 2021 Mar 22. pii: S0167-5273(21)00550.
    PubMed     Abstract available


  333. PELLICCIA F, Rosano GMC, Mehran R
    Corrigendum to "Gender-related differences after acute myocardial infarction: A major global health challenge" [International Journal of Cardiology Volume 311 (2020), 18-19 / DOI: https://doi.org/10.1016/j.ijcard.2020.04.023].
    Int J Cardiol. 2021 Mar 20. pii: S0167-5273(21)00481.
    PubMed    


  334. LIU Y, Wang W, Song J, Zhang K, et al
    Prognosis of spontaneous myocardial infarction and various definitions of periprocedural myocardial infarction in patients who underwent percutaneous coronary intervention.
    Int J Cardiol. 2021 Mar 17. pii: S0167-5273(21)00475.
    PubMed     Abstract available


  335. LEDDA RE, Milanese G, Sverzellati N
    Might EAT composition help to predict coronary artery disease severity?
    Int J Cardiol. 2021;327:39.
    PubMed    


  336. PAPP S, Barczi G, Karady J, Kolossvary M, et al
    Coronary plaque burden of the left anterior descending artery in patients with or without myocardial bridge: A case-control study based on coronary CT-angiography.
    Int J Cardiol. 2021;327:231-235.
    PubMed     Abstract available


  337. PAVASINI R, Cardelli LS, Piredda A, Tonet E, et al
    Diastolic dysfunction, frailty and prognosis in elderly patients with acute coronary syndromes.
    Int J Cardiol. 2021;327:31-35.
    PubMed     Abstract available


  338. YING S, Li X
    Renal insufficiency and outcomes in patients with acute coronary syndrome.
    Int J Cardiol. 2021;327:36.
    PubMed    


  339. HUANG W, Wu X, Xue Y, Zhou Y, et al
    Reply to the Letter to the Editor: "The role of miRNA in regulating epicardial adipose tissue (EAT) inflammation".
    Int J Cardiol. 2021;327:37.
    PubMed    


  340. JINNOUCHI H, Sato Y, Cheng Q, Janifer C, et al
    Thromboresistance and endothelial healing in polymer-coated versus polymer-free drug-eluting stents: Implications for short-term dual anti-platelet therapy.
    Int J Cardiol. 2021;327:52-57.
    PubMed     Abstract available


  341. LI L, Guan C, Meng S, Bai Y, et al
    Short- and long-term functional results following drug-coated balloons versus drug- eluting stents in small coronary vessels: The RESTORE quantitative flow ratio study.
    Int J Cardiol. 2021;327:45-51.
    PubMed     Abstract available


  342. RIEHLE L, Frohlich GM
    Reply to "Comment on: Changes in treatment for NSTEMI in women and the elderly over the past 16 years in a large real-world population".
    Int J Cardiol. 2021;327:38.
    PubMed    


  343. TAMARAPPOO B, Samuel TJ, Elboudwarej O, Thomson LEJ, et al
    Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) Project.
    Int J Cardiol. 2021;327:25-30.
    PubMed     Abstract available


  344. ZHOU J, Chin CT, Huang X, Guo N, et al
    Long-term antiplatelet therapy in medically managed non-ST-segment elevation acute coronary syndromes: The EPICOR Asia study.
    Int J Cardiol. 2021;327:19-24.
    PubMed     Abstract available


  345. LEONE AM, Arioti M, Cialdella P, Vergallo R, et al
    Prognostic impact of FFR/contrast FFR discordance.
    Int J Cardiol. 2021;327:40-44.
    PubMed     Abstract available


  346. GRESELE P, Guglielmini G, Del Pinto M, Calabro P, et al
    Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry.
    Int J Cardiol. 2021;327:176-182.
    PubMed     Abstract available


  347. SCHIELE F, Quignot N, Khachatryan A, Gusto G, et al
    Clinical impact and room for improvement of intensity and adherence to lipid lowering therapy: Five years of clinical follow-up from 164,565 post-myocardial infarction patients.
    Int J Cardiol. 2021 Mar 8. pii: S0167-5273(21)00464.
    PubMed     Abstract available


  348. BURRAGE MK, Shanmuganathan M, Masi A, Hann E, et al
    Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls.
    Int J Cardiol. 2021 Mar 8. pii: S0167-5273(21)00467.
    PubMed     Abstract available


  349. SHAO X, Chen Y, Su T, Shao X, et al
    Reply to "miRNA-1: A novel, potential therapeutic target in the treatment of acute myocardial infarction?"
    Int J Cardiol. 2021 Mar 8. pii: S0167-5273(21)00468.
    PubMed    


  350. STIENEN S, Ferreira JP, Bar C, Thum T, et al
    Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunction.
    Int J Cardiol. 2021 Mar 4. pii: S0167-5273(21)00399.
    PubMed     Abstract available


  351. LAWLESS M, Harrison AS, Doherty P
    Multiple interventions following an acute coronary syndrome event increase uptake into cardiac rehabilitation.
    Int J Cardiol. 2021;326:1-5.
    PubMed     Abstract available


  352. ZHAI Y, Yang J, Zhang J, Yang J, et al
    miRNA-3614 derived from epicardial adipose tissue: A novel target for ischemic heart diseases.
    Int J Cardiol. 2021;326:157.
    PubMed    


  353. SHIMA Y, Miura K, Shimada T, Ohya M, et al
    Impact of ischemic risk factors on long-term outcomes in patients with and without high bleeding risk.
    Int J Cardiol. 2021;326:12-18.
    PubMed     Abstract available


  354. BRUNO VD, Zakkar M
    Instantaneous wave- free ratio for decision making in cardiac surgery, an important step in the right direction.
    Int J Cardiol. 2021;326:71-72.
    PubMed    


  355. SABBAH M, Engstrom T, Nepper-Christensen L, Lonborg J, et al
    Does infarct localization and collateral supply confound the association between antiplatelet treatment and infarct size in STEMI?
    Int J Cardiol. 2021;326:42.
    PubMed    


  356. LI D, Xiong G, Zeng H, Zhou Q, et al
    Machine learning-aided risk stratification system for the prediction of coronary artery disease.
    Int J Cardiol. 2021;326:30-34.
    PubMed     Abstract available


    February 2021
  357. WANG JD, Qiu F, Li W
    miRNA-1: A novel, potential therapeutic target in the treatment of acute myocardial infarction?
    Int J Cardiol. 2021 Feb 28. pii: S0167-5273(21)00374.
    PubMed    


  358. TZIAKAS D, Chalikias G, Al-Lamee R, Kaski JC, et al
    Non ST-elevation myocardial infarction (NSTEMI) patients with total coronary artery occlusion: More than meets the eye.
    Int J Cardiol. 2021 Feb 26. pii: S0167-5273(21)00367.
    PubMed    


  359. LIU H, Xie G, Huang W, Liu J, et al
    Rationale and design of a multicenter, randomized, patients-blinded two-stage clinical trial on effects of endothelial function test in patients with non-obstructive coronary artery disease (ENDOFIND).
    Int J Cardiol. 2021;325:16-22.
    PubMed     Abstract available


  360. CASE BC, Yerasi C, Forrestal BJ, Shlofmitz E, et al
    Intravascular ultrasound guidance in the evaluation and treatment of left main coronary artery disease.
    Int J Cardiol. 2021;325:168-175.
    PubMed     Abstract available


  361. FRACASSI F, Niccoli G, Cosentino N, Eligini S, et al
    Human monocyte-derived macrophages: Pathogenetic role in plaque rupture associated to systemic inflammation.
    Int J Cardiol. 2021;325:1-8.
    PubMed     Abstract available


  362. VENETSANOS D, Omerovic E, Sarno G, Pagonis C, et al
    Long term outcome after treatment of de novo coronary artery lesions using three different drug coated balloons.
    Int J Cardiol. 2021;325:30-36.
    PubMed     Abstract available


  363. CHOI KH, Lee SH, Lee JM, Hwang D, et al
    Clinical relevance and prognostic implications of contrast quantitative flow ratio in patients with coronary artery disease.
    Int J Cardiol. 2021;325:23-29.
    PubMed     Abstract available


  364. LAUKKANEN JA, Kunutsor SK
    Revascularization versus medical therapy for the treatment of stable coronary artery disease: A meta-analysis of contemporary randomized controlled trials.
    Int J Cardiol. 2021;324:13-21.
    PubMed     Abstract available


  365. KATAOKA T, Harada K, Tanaka A, Onishi T, et al
    Relationship between epicardial adipose tissue volume and coronary artery spasm.
    Int J Cardiol. 2021;324:8-12.
    PubMed     Abstract available


  366. SURUGA K, Miyoshi T, Kotani K, Ichikawa K, et al
    Higher oxidized high-density lipoprotein to apolipoprotein A-I ratio is associated with high-risk coronary plaque characteristics determined by CT angiography.
    Int J Cardiol. 2021;324:193-198.
    PubMed     Abstract available


  367. IANNACCONE M, Albani S, Giannini F, Colangelo S, et al
    Short term outcomes of Impella in cardiogenic shock: A review and meta-analysis of observational studies.
    Int J Cardiol. 2021;324:44-51.
    PubMed     Abstract available


  368. WADA T, Shiono Y, Kubo T, Honda K, et al
    Impact of instantaneous wave-free ratio on graft failure after coronary artery bypass graft surgery.
    Int J Cardiol. 2021;324:23-29.
    PubMed     Abstract available


  369. HUANG W, Wu X, Xue Y, Zhou Y, et al
    MicroRNA-3614 regulates inflammatory response via targeting TRAF6-mediated MAPKs and NF-kappaB signaling in the epicardial adipose tissue with coronary artery disease.
    Int J Cardiol. 2021;324:152-164.
    PubMed     Abstract available


  370. ALMENDRO-DELIA M, Seoane Garcia T, Villar Calle P, Garcia Gonzalez N, et al
    Prevalence and clinical significance of totally occluded infarct-related arteries in patients with non-ST-segment elevation acute coronary syndromes.
    Int J Cardiol. 2021;324:1-7.
    PubMed     Abstract available


  371. MADIAS JE
    Electrocardiogram features and course in patients with takotsubo syndrome.
    Int J Cardiol. 2021;324:22.
    PubMed    


    January 2021
  372. NICCOLI G, Morrone D, De Rosa S, Montone RA, et al
    The central role of invasive functional coronary assessment for patients with ischemic heart disease.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00137.
    PubMed    


  373. NOURAEI H, Rabkin SW
    A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00134.
    PubMed     Abstract available


  374. DAI M, Zhong S
    A pilot study to construct the ceRNA regulatory network of a specific lncRNA in coronary heart disease.
    Int J Cardiol. 2021 Jan 29. pii: S0167-5273(21)00116.
    PubMed    


  375. XIE MY, Hou LJ
    LncRNA GAS5 aggravates myocardial infarction by sponging miR-26b.
    Int J Cardiol. 2021 Jan 27. pii: S0167-5273(21)00103.
    PubMed    


  376. DE ROQUETAILLADE C, Chousterman BG, Tomasoni D, Zeitouni M, et al
    Unusual arterial thrombotic events in Covid-19 patients.
    Int J Cardiol. 2021;323:281-284.
    PubMed     Abstract available


  377. SCHIAVONE M, Gasperetti A, Mancone M, Curnis A, et al
    Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience.
    Int J Cardiol. 2021;323:276-280.
    PubMed     Abstract available


  378. SONG X
    The role of miRNA in regulating epicardial adipose tissue (EAT) inflammation.
    Int J Cardiol. 2021;323:22.
    PubMed    


  379. SARAIVA FA, Cerqueira RJ, Savarese G, Leite-Moreira AF, et al
    The tight tie of MAG versus SAG in CABG.
    Int J Cardiol. 2021;323:26.
    PubMed    


  380. SELVANAYAGAM JB, Ananthakrishna R, Shirodaria C, Channon K, et al
    Timing of cardiovascular magnetic resonance in clinical trials evaluating cardioprotective therapies to reduce infarct size.
    Int J Cardiol. 2021;323:272-274.
    PubMed    


  381. JOLOBE OMP
    The differential diagnosis of STEMI should also be taken into account.
    Int J Cardiol. 2021;323:19.
    PubMed    


  382. GUI D, Huang W
    Coronary artery disease is accompanied by increased epicardial fat volume.
    Int J Cardiol. 2021;323:21.
    PubMed    


  383. PENG Y, Du X, Li X, Ji J, et al
    Association of renal insufficiency with treatments and outcomes in patients with acute coronary syndrome in China.
    Int J Cardiol. 2021;323:7-12.
    PubMed     Abstract available


  384. TZIAKAS D, Chalikias G, Al-Lamee R, Kaski JC, et al
    Total coronary occlusion in non ST elevation myocardial infarction: Time to change our practice?
    Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34330.
    PubMed     Abstract available


  385. LOW CJ, Leow AS, Syn NL, Tan BY, et al
    Outcomes of left ventricular thrombosis in post-acute myocardial infarction patients stratified by antithrombotic strategies: A meta-analysis with meta-regression.
    Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34335.
    PubMed     Abstract available


  386. CAI Q, Gao ML, Huang LS, Pan LH, et al
    lncRNA H19/miRNA-1: Another potential mechanism for treating myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2021;322:57.
    PubMed    


  387. LOPEZ-DE-SA E
    Acute coronary occlusion in non-STEMI: If you change the way you look at things, the things you look at change.
    Int J Cardiol. 2021;322:49-50.
    PubMed    


  388. WU X, Ma JN, Shen LJ, Hu SY, et al
    Reply to "The differential diagnosis of STEMI should also be taken into account".
    Int J Cardiol. 2021;322:55.
    PubMed    


  389. OZGEYIK M, Okay Ozgeyik M, Yildirim OT
    Comment on: Changes in treatment for NSTEMI in women and the elderly over the past 16 years in a large real-world population.
    Int J Cardiol. 2021;322:56.
    PubMed    


  390. IBRAHIM IM, Farag EM, Tabl MAE, Abdelaziz M, et al
    Relationship between sclerostin and coronary tortuosity in postmenopausal females with non-obstructive coronary artery disease.
    Int J Cardiol. 2021;322:29-33.
    PubMed     Abstract available


  391. KEECH A, Way K, Holgate K, Fildes J, et al
    HIIT for post-COVID patients within cardiac rehabilitation: Response to letter to the editor.
    Int J Cardiol. 2021;322:291-292.
    PubMed    


  392. YAMADA H
    Epicardial adipose tissue volume is not a simple marker of coronary artery disease.
    Int J Cardiol. 2021;322:45.
    PubMed    


  393. LAKSHMANAN S, Budoff MJ
    Where ISCHEMIA fails, coronary CTA shines.
    Int J Cardiol. 2021;322:40-42.
    PubMed    


  394. LUSINI M, Nenna A, Chello M
    Endocannabinoid system: A new player in the percutaneous and surgical treatment of coronary artery disease?
    Int J Cardiol. 2021;322:211-212.
    PubMed    


  395. KATAOKA Y, Doi T
    Coronary artery ectasia: Importance of its risk stratification and management.
    Int J Cardiol. 2021;322:43-44.
    PubMed    


  396. KATAJA A, Tarvasmaki T, Lassus J, Sionis A, et al
    Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - Insights from the CardShock study.
    Int J Cardiol. 2021;322:191-196.
    PubMed     Abstract available


  397. WU L, Yu J, Wang Q, Lu Y, et al
    Effects of nalbuphine on the cardioprotective effect of morphine in rats.
    Int J Cardiol. 2021;322:207-210.
    PubMed     Abstract available


  398. DAI Y, Huang J, Chen Y, Chang S, et al
    Circulating CD34+VEGFR-2+ endothelial progenitor cells correlate with revascularization-mediated long-term improvement of cardiac function in patients with coronary chronic total occlusions.
    Int J Cardiol. 2021;322:1-8.
    PubMed     Abstract available


  399. MANGIACAPRA F, Bressi E, Viscusi MM, Creta A, et al
    Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study.
    Int J Cardiol. 2021;322:16-22.
    PubMed     Abstract available


  400. POLYAKOVA EA, Zaraiskii MI, Mikhaylov EN, Baranova EI, et al
    Association of myocardial and serum miRNA expression patterns with the presence and extent of coronary artery disease: A cross-sectional study.
    Int J Cardiol. 2021;322:9-15.
    PubMed     Abstract available


    December 2020
  401. SONG X, Zheng Y, Xue W, Li L, et al
    Identification of risk genes related to myocardial infarction and the construction of early SVM diagnostic model.
    Int J Cardiol. 2020 Dec 19. pii: S0167-5273(20)34255.
    PubMed     Abstract available


  402. EMRICH T, Kros M, Schoepf UJ, Geyer M, et al
    Cardiac magnetic resonance imaging features prognostic information in patients with suspected myocardial infarction with non-obstructed coronary arteries.
    Int J Cardiol. 2020 Dec 10. pii: S0167-5273(20)34257.
    PubMed     Abstract available


  403. TILLER C, Reindl M, Holzknecht M, Lechner I, et al
    High sensitivity C-reactive protein is associated with worse infarct healing after revascularized ST-elevation myocardial infarction.
    Int J Cardiol. 2020 Dec 9. pii: S0167-5273(20)34253.
    PubMed     Abstract available


  404. LENG WX, Yang JG, Li XD, Jiang WY, et al
    Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment-elevation myocardial infarction during the COVID-19 pandemic-The experience from the largest cardiovascular-specific centre in China.
    Int J Cardiol. 2020 Dec 8. pii: S0167-5273(20)34245.
    PubMed     Abstract available


  405. SUN Y, Lin J, Huang S, Xu X, et al
    Preliminary verification of lncRNA ENST00000609755.1 potential ceRNA regulatory network in coronary heart disease.
    Int J Cardiol. 2020 Dec 3. pii: S0167-5273(20)34233.
    PubMed     Abstract available


  406. PARK YJ, Lee JH, Kim HJ, Park BE, et al
    Variation in treatment strategy for non-ST segment elevation myocardial infarction: A multilevel methodological approach.
    Int J Cardiol. 2020 Dec 2. pii: S0167-5273(20)34228.
    PubMed     Abstract available


  407. LI Y, Liu D, Wu H
    HIIT: A potential rehabilitation treatment in COVID-19 pneumonia with heart disease.
    Int J Cardiol. 2020;320:183.
    PubMed    


  408. KISHI T
    Clinical implication of left ventricular preload and afterload reduction during venoarterial extracorporeal membrane oxygenation.
    Int J Cardiol. 2020;320:124-125.
    PubMed    


    November 2020
  409. KOBO O, Contractor T, Mohamed MO, Parwani P, et al
    Impact of pre-existent vascular and poly-vascular disease on acute myocardial infarction management and outcomes: An analysis of 2 million patients from the National Inpatient Sample.
    Int J Cardiol. 2020 Nov 30. pii: S0167-5273(20)34220.
    PubMed     Abstract available


  410. CILIBERTI G, Verdoia M, Merlo M, Zilio F, et al
    Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry.
    Int J Cardiol. 2020 Nov 23. pii: S0167-5273(20)34163.
    PubMed     Abstract available


  411. BARBATO E, Knuuti J, Wijns W
    From fallacies to reality: Focus on fractional flow reserve.
    Int J Cardiol. 2020;319:61.
    PubMed    


  412. CHOUDHARY R, Gautam DK
    Optimal antiplatelet strategy in Asian patients presenting with acute coronary syndrome.
    Int J Cardiol. 2020;319:37.
    PubMed    


  413. WANG H, Zhang Y, Shen Z, Fang L, et al
    Response to letter to the editor on "Percutaneous coronary intervention underperforms in Takayasu Arteritis".
    Int J Cardiol. 2020;319:38-39.
    PubMed    


  414. DUUS LS, Pedersen S, Ravnkilde K, Galatius S, et al
    Association between the E-wave propagation index and left ventricular thrombus formation after ST-elevation myocardial infarction.
    Int J Cardiol. 2020 Nov 2. pii: S0167-5273(20)34071.
    PubMed     Abstract available


  415. AGSTAM S, Gupta A
    Percutaneous coronary intervention underperforms in Takayasu Arteritis.
    Int J Cardiol. 2020;318:144.
    PubMed    


  416. VINCI MC, Bassetti B, Pompilio G
    Endothelial progenitors: When confusion may give rise to new understanding.
    Int J Cardiol. 2020;318:121-122.
    PubMed    


  417. LANDI A, De Servi S
    Time-dependent impact of Ticagrelor and Prasugrel on infarct size: Looking beyond antiplatelet effect.
    Int J Cardiol. 2020;318:26.
    PubMed    


  418. DUFLOS C, Roubille C, Roubille F
    By half decrease of cardiovascular mortality in a Western country between 2000 and 2015: A contrasted picture advocating for a better management of comorbidities.
    Int J Cardiol. 2020;318:145-146.
    PubMed    


    October 2020
  419. RAVAL AN, Johnston PV, Duckers HJ, Cook TD, et al
    Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.
    Int J Cardiol. 2020 Oct 19. pii: S0167-5273(20)33996.
    PubMed     Abstract available


  420. GOULD KL
    FFR at high heart rate - Unexpected physiologic insights.
    Int J Cardiol. 2020;317:44-46.
    PubMed    


  421. ROKOS IC
    Artificial intelligence for STEMI detection: The "Shanghai Algorithm" provides a step forward.
    Int J Cardiol. 2020;317:231-232.
    PubMed    


  422. LEONE AM
    Post PCI FFR: More questions than answers?
    Int J Cardiol. 2020;317:42-43.
    PubMed    


  423. VALLABHAJOSYULA S
    Reply to 'The potentially fatal consequences of fibrinolysis in misdiagnosed patients with aortic dissection'.
    Int J Cardiol. 2020 Oct 5. pii: S0167-5273(20)33910.
    PubMed    


  424. MYHRE PL, Lyngbakken MN, Rosjo H, Omland T, et al
    Removing stable and adding precision to chronic coronary artery disease.
    Int J Cardiol. 2020;316:54-56.
    PubMed    


    September 2020
  425. GIRALT T, Ribas N, Freixa X, Sabate M, et al
    Impact of pre-angioplasty antithrombotic therapy administration on coronary reperfusion in ST-segment elevation myocardial infarction: Does time matter?
    Int J Cardiol. 2020 Sep 26. pii: S0167-5273(20)33839.
    PubMed     Abstract available


  426. ZHU F, Liu Y, Tang K
    MicroRNA-26b might be a novel therapeutic target in the treatment of myocardial infarction.
    Int J Cardiol. 2020 Sep 16. pii: S0167-5273(20)33741.
    PubMed    


  427. JOLOBE OMP
    The potentially fatal consequences of fibrinolysis in misdiagnosed subjects with aortic dissection.
    Int J Cardiol. 2020 Sep 10. pii: S0167-5273(20)33798.
    PubMed    


    August 2020
  428. PASTORI D, Carnevale R, Stanzione R, Nocella C, et al
    T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort.
    Int J Cardiol. 2020 Aug 27. pii: S0167-5273(20)33704.
    PubMed     Abstract available


  429. ZHAO J, Pan J
    Circulating Serpina3 might be a new potential biomarker to predict the clinical outcomes in AMI.
    Int J Cardiol. 2020;312:108.
    PubMed    


  430. LUCINI D, Pagani M
    Heart rate variability, autonomic regulation and myocardial ischemia.
    Int J Cardiol. 2020;312:22-23.
    PubMed    


    July 2020
  431. GAIBAZZI N
    Are we "bridging" the gap?
    Int J Cardiol. 2020;311:114-115.
    PubMed    


  432. LAUKKANEN JA, Kunutsor SK
    A potential case for the routine assessment of cardiorespiratory fitness level in clinical practice.
    Int J Cardiol. 2020;310:145-146.
    PubMed    


  433. YANG C, Fan Z, Yang J
    Urgent to correctly understand the role of aspirin in cardiovascular disease.
    Int J Cardiol. 2020;310:33.
    PubMed    


    June 2020
  434. SCARSINI R, Lunardi M, Venturi G, Pighi M, et al
    Long-term variations of FFR and iFR after transcatheter aortic valve implantation.
    Int J Cardiol. 2020 Jun 3. pii: S0167-5273(20)31098.
    PubMed     Abstract available


    May 2020
  435. LIMBRUNO U, Goette A, De Caterina R
    Commentary: Temporarily omitting oral anticoagulants early after stenting for acute coronary syndromes patients with atrial fibrillation.
    Int J Cardiol. 2020 May 7. pii: S0167-5273(20)32667.
    PubMed     Abstract available


  436. SVENNINGSSON MM, Svingen GFT, Lysne V, Ueland PM, et al
    Transsulfuration metabolites and the association with incident atrial fibrillation - An observational cohort study among Norwegian patients with stable angina pectoris.
    Int J Cardiol. 2020 May 7. pii: S0167-5273(20)30694.
    PubMed     Abstract available


    April 2020
  437. PUGLIESE NR, Masi S
    Circulating interleukins, coronary artery disease, ischemic stroke and atrial fibrillation: Connecting the dots between inflammation and cardiovascular disease.
    Int J Cardiol. 2020 Apr 21. pii: S0167-5273(20)31424.
    PubMed    


    March 2020
  438. YUAN S, Lin A, He QQ, Burgess S, et al
    Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study.
    Int J Cardiol. 2020 Mar 21. pii: S0167-5273(20)30701.
    PubMed     Abstract available


  439. ALHAKAK AS, Mogelvang R, Schnohr P, Modin D, et al
    The cardiac isovolumetric contraction time is an independent predictor of incident heart failure in the general population.
    Int J Cardiol. 2020 Mar 19. pii: S0167-5273(19)35169.
    PubMed     Abstract available


  440. GOEL S, Pasam RT, Chava S, Gotesman J, et al
    Orbital atherectomy versus rotational atherectomy: A systematic review and meta-analysis.
    Int J Cardiol. 2020;303:16-21.
    PubMed     Abstract available


  441. GENCER B, Carballo D, Nanchen D, Koskinas KC, et al
    Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohort.
    Int J Cardiol. 2020;303:8-13.
    PubMed     Abstract available


  442. NUNEZ J, Palau P, Sastre C, D'Ascoli G, et al
    Sex-differential effect of frailty on long-term mortality in elderly patients after an acute coronary syndrome.
    Int J Cardiol. 2020;302:30-33.
    PubMed     Abstract available


  443. SOARES A, Brown DL
    The fallacies of fractional flow reserve.
    Int J Cardiol. 2020;302:34-35.
    PubMed    


  444. KITE TA, Gaunt H, Banning AS, Roberts E, et al
    Clinical outcomes of patients discharged from the Rapid Access Chest Pain Clinic with non-anginal chest pain: A retrospective cohort study.
    Int J Cardiol. 2020;302:1-4.
    PubMed     Abstract available


    February 2020
  445. MICALI LR, Parise G, Moula AI, Alayed Y, et al
    Are recurrence of ischemic mitral regurgitation and left ventricular reverse remodeling after restrictive annuloplasty ring dependent?
    Int J Cardiol. 2020 Feb 27. pii: S0167-5273(19)34381.
    PubMed     Abstract available


  446. RASHID M, Curzen N, Kinnaird T, Lawson CA, et al
    Baseline risk, timing of invasive strategy and guideline compliance in NSTEMI: Nationwide analysis from MINAP.
    Int J Cardiol. 2020;301:7-13.
    PubMed     Abstract available


  447. DENG XQ, Xu XJ, Wu SH, Li H, et al
    Association between resting painless ST-segment depression with sudden cardiac death in middle-aged population: A prospective cohort study.
    Int J Cardiol. 2020;301:1-6.
    PubMed     Abstract available


  448. LADDU DR, Ozemek C, Hauer TL, Rouleau CR, et al
    Cardiometabolic responses to cardiac rehabilitation in people with and without diabetes.
    Int J Cardiol. 2020;301:156-162.
    PubMed     Abstract available


  449. BIANCO M, D'ascenzo F, Raposeiras Roubin S, Kinnaird T, et al
    Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor.
    Int J Cardiol. 2020;301:200-206.
    PubMed     Abstract available


  450. CARRIE D, Berland J, Verheye S, Hauptmann KE, et al
    Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions.
    Int J Cardiol. 2020;301:50-55.
    PubMed     Abstract available


  451. ELY PIZZATO P, Samdani AJ, Vergara-Martel A, Palma Dallan LA, et al
    Feasibility of coronary angiogram-derived vessel fractional flow reserve in the setting of standard of care percutaneous coronary intervention and its correlation with invasive FFR.
    Int J Cardiol. 2020;301:45-49.
    PubMed     Abstract available


  452. RAMASAMY A, Chen Y, Zanchin T, Jones DA, et al
    Optical coherence tomography enables more accurate detection of functionally significant intermediate non-left main coronary artery stenoses than intravascular ultrasound: A meta-analysis of 6919 patients and 7537 lesions.
    Int J Cardiol. 2020;301:226-234.
    PubMed     Abstract available


  453. PONTONE G, Guaricci AI, Palmer SC, Andreini D, et al
    Diagnostic performance of non-invasive imaging for stable coronary artery disease: A meta-analysis.
    Int J Cardiol. 2020;300:276-281.
    PubMed     Abstract available


  454. QU Y, Yang J, Zhang F, Li C, et al
    Relationship between body mass index and outcomes of coronary artery disease in Asian population: Insight from the FOCUS registry.
    Int J Cardiol. 2020;300:262-267.
    PubMed     Abstract available


  455. QUINTANA RA, Monlezun DJ, Davogustto G, Saenz HR, et al
    Outcomes following percutaneous coronary intervention in patients with cancer.
    Int J Cardiol. 2020;300:106-112.
    PubMed     Abstract available


  456. WITBERG G, Zusman O, Bental T, Plakht I, et al
    Validation of the DAPT score in real-world patients undergoing coronary stent implantation.
    Int J Cardiol. 2020;300:99-105.
    PubMed     Abstract available


  457. CONTE E, Sonck J, Mushtaq S, Collet C, et al
    FFRCT and CT perfusion: A review on the evaluation of functional impact of coronary artery stenosis by cardiac CT.
    Int J Cardiol. 2020;300:289-296.
    PubMed     Abstract available


  458. HIDEO-KAJITA A, Garcia-Garcia HM, Kolm P, Azizi V, et al
    Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12months: Pooled patient level analysis from BIOSOLVE II-III and BIOFLOW II trials.
    Int J Cardiol. 2020;300:60-65.
    PubMed     Abstract available


  459. KERKMEIJER LSM, Tijssen RYG, Hofma SH, Pinxterhuis TH, et al
    A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial.
    Int J Cardiol. 2020;300:93-98.
    PubMed     Abstract available


    January 2020
  460. BUTTY A, Gencer B, Koskinas KC, Carballo D, et al
    Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitors.
    Int J Cardiol. 2020;299:289-295.
    PubMed     Abstract available


  461. PARIKH RV, Pargaonkar V, Ball RL, Kobayashi Y, et al
    Asymmetric dimethylarginine predicts impaired epicardial coronary vasomotion in patients with angina in the absence of obstructive coronary artery disease.
    Int J Cardiol. 2020;299:7-11.
    PubMed     Abstract available


  462. NUNEZ-GIL IJ, Cerrato E, Bollati M, Nombela-Franco L, et al
    Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR).
    Int J Cardiol. 2020;299:49-55.
    PubMed     Abstract available


  463. LEONE AM, Campo G, Gallo F, Pavasini R, et al
    Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis.
    Int J Cardiol. 2020;299:93-99.
    PubMed     Abstract available


  464. AL-RASHID F, Totzeck M, Mahabadi AA, Johannsen L, et al
    Safety and efficacy of a novel algorithm to guide decision-making in high-risk interventional coronary procedures.
    Int J Cardiol. 2020;299:87-92.
    PubMed     Abstract available


  465. BRANKOVIC M, Kardys I, van den Berg V, Oemrawsingh R, et al
    Evolution of renal function and predictive value of serial renal assessments among patients with acute coronary syndrome: BIOMArCS study.
    Int J Cardiol. 2020;299:12-19.
    PubMed     Abstract available


  466. KOO CY, Chua AP, Kristanto W, Koh EH, et al
    Screening and treatment of obstructive sleep apnea in acute coronary syndrome. A randomized clinical trial.
    Int J Cardiol. 2020;299:20-25.
    PubMed     Abstract available


  467. XENOGIANNIS I, Karmpaliotis D, Alaswad K, Jaffer FA, et al
    Impact of concomitant treatment of non-chronic total occlusion lesions at the time of chronic total occlusion intervention.
    Int J Cardiol. 2020;299:75-80.
    PubMed     Abstract available


  468. BAE JH, Corban MT, Seo YH, Kim T, et al
    Ten-year clinical outcomes of an intermediate coronary lesion; prognosis and predictors of major adverse cardiovascular events.
    Int J Cardiol. 2020;299:26-30.
    PubMed     Abstract available


  469. HONG SJ, Park KH, Ahn CM, Kim JS, et al
    Severe acute stent malapposition follow-up: 3-month and 12-month serial quantitative analyses by optical coherence tomography.
    Int J Cardiol. 2020;299:81-86.
    PubMed     Abstract available


  470. KINNAIRD T, Kwok CS, Davies R, Calvert PA, et al
    Coronary perforation complicating percutaneous coronary intervention in patients presenting with an acute coronary syndrome: An analysis of 1013 perforation cases from the British Cardiovascular Intervention Society database.
    Int J Cardiol. 2020;299:37-42.
    PubMed     Abstract available


  471. KEECH A, Holgate K, Fildes J, Indraratna P, et al
    High-intensity interval training for patients with coronary artery disease: Finding the optimal balance.
    Int J Cardiol. 2020;298:8-14.
    PubMed     Abstract available


  472. SILVA AC, de Antonio VZ, Sroubek J, Gervino E, et al
    Exercise and pharmacologic stress-induced interlead T-wave heterogeneity analysis to detect clinically significant coronary artery stenosis.
    Int J Cardiol. 2020;298:32-38.
    PubMed     Abstract available


    December 2019
  473. RUAN Y, Robinson NB, Naik A, Silva M, et al
    Effect of atrial pacing on post-operative atrial fibrillation following coronary artery bypass grafting: Pairwise and network meta-analyses.
    Int J Cardiol. 2019 Dec 6. pii: S0167-5273(19)35145.
    PubMed     Abstract available


    November 2019
  474. MARCUS G, Shimony S, Stein GY, Matezky S, et al
    Incidence, predictors and prognostic implications of dyspnea at admission among acute coronary syndrome patients without heart failure.
    Int J Cardiol. 2019 Nov 9. pii: S0167-5273(19)32270.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: